US20060115785A1 - Systems and methods for intra-oral drug delivery - Google Patents

Systems and methods for intra-oral drug delivery Download PDF

Info

Publication number
US20060115785A1
US20060115785A1 US11/000,282 US28204A US2006115785A1 US 20060115785 A1 US20060115785 A1 US 20060115785A1 US 28204 A US28204 A US 28204A US 2006115785 A1 US2006115785 A1 US 2006115785A1
Authority
US
United States
Prior art keywords
substance
substances
agent
appliance
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/000,282
Inventor
Chunhua Li
Wenda Carlyle
Philippe Smedt
Amir Abolfathi
Erice Kuo
Robert Tricca
Jennifer Chen
Benjamin Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Align Technology Inc
Original Assignee
Align Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Align Technology Inc filed Critical Align Technology Inc
Priority to US11/000,282 priority Critical patent/US20060115785A1/en
Priority to PCT/US2005/043431 priority patent/WO2006060547A2/en
Priority to EP05852615.3A priority patent/EP1824410B1/en
Priority to JP2007543616A priority patent/JP5004295B2/en
Assigned to ALIGN TECHNOLOGY, INC. reassignment ALIGN TECHNOLOGY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARLYLE, WENDA C., DE SMEDT, PHILIPPE, ABOLFATHI, AMIR, CHEN, JENNIFER C., KUO, ERIC E., LI, CHUNHUA, TRICCA, ROBERT E., WU, BENJAMIN M.
Publication of US20060115785A1 publication Critical patent/US20060115785A1/en
Priority to US11/982,301 priority patent/US8075309B2/en
Priority to US13/324,882 priority patent/US8439674B2/en
Priority to JP2012023628A priority patent/JP2012086076A/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00Dental auxiliary appliances
    • A61C19/06Implements for therapeutic treatment
    • A61C19/063Medicament applicators for teeth or gums, e.g. treatment with fluorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C7/00Orthodontics, i.e. obtaining or maintaining the desired position of teeth, e.g. by straightening, evening, regulating, separating, or by correcting malocclusions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C7/00Orthodontics, i.e. obtaining or maintaining the desired position of teeth, e.g. by straightening, evening, regulating, separating, or by correcting malocclusions
    • A61C7/008Orthodontics, i.e. obtaining or maintaining the desired position of teeth, e.g. by straightening, evening, regulating, separating, or by correcting malocclusions using vibrating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C7/00Orthodontics, i.e. obtaining or maintaining the desired position of teeth, e.g. by straightening, evening, regulating, separating, or by correcting malocclusions
    • A61C7/08Mouthpiece-type retainers or positioners, e.g. for both the lower and upper arch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools

Definitions

  • the present invention is related to systems and methods for intra-oral drug delivery.
  • the repositioning of teeth may be accomplished with the use of a series of removable elastic positioning appliances such as the Invisalign® system available from Align Technology, Inc., the assignee of the present invention.
  • Such appliances have a thin shell of elastic material that generally conforms to a patient's teeth but is slightly out of alignment with an initial or immediately prior tooth configuration. Placement of the elastic positioner over the teeth applies controlled forces in specific locations to gradually move the teeth into the new configuration.
  • the appliance is effective in repositioning teeth when it is placed over the patient's teeth. Removal of the appliance for any reason interrupts the treatment plan and lengthens the overall period of treatment. Therefore, removal of the appliance should be minimized for effective and timely treatment.
  • a number of dental and periodontal therapies which may be desired or required by the patient may not be effectively utilized while the appliance is in place. Such therapies may be prescribed by a practitioner to improve oral health or they may be requested by the patient for cosmetic purposes.
  • the '382 patent discloses devices, systems and methods for orthodontic treatment using elastic repositioning appliances while concurrently providing dental and periodontal therapies.
  • Such therapies are traditionally provided with the use of a variety of accessories and devices which are applied when the repositioning appliance is removed from the patient's mouth.
  • the '382 system eliminates the need for such removal and additional devices by incorporating these therapies into the repositioning appliance.
  • United States Patent Application 20040115587 discloses an orthodontic treatment involving applying force to reposition teeth and administering a tissue remodeling and/or an angiogenic substance(s) to the periodontal tissue surrounding the teeth to be moved.
  • the substance(s) may be delivered before, during, or after the teeth are moved, and the substance(s) may be selectively applied only to those teeth undergoing movement at any particular time.
  • the substance(s) may be applied from the dental repositioning appliance or may be applied separately, either topically or by injection.
  • FIG. 1 shows an exemplary method for intra-oral delivery of a substance to an individual.
  • FIGS. 2A-2B are exemplary removable appliances adapted to fit over teeth on a jaw.
  • FIG. 2C shows a cross-sectional view of the appliance of FIG. 2B on an exemplary tooth.
  • FIG. 2D is a cross sectional view of FIG. 2C without the tooth and gum line.
  • FIGS. 2E-2F show additional embodiments of appliances for delivery of drugs or agents.
  • FIG. 3 illustrates another drug delivery system.
  • FIGS. 4A-4E illustrate various views of a bracket with a reservoir.
  • FIGS. 5A-5E show various embodiments of drug delivery systems.
  • FIG. 6A illustrates an embodiment where energy is applied to an appliance to effect teeth movement or drug delivery.
  • FIG. 6B illustrates an embodiment where energy is applied to wires to effect teeth movement or drug delivery.
  • the system enables drugs or therapeutic agents to be delivered through the mouth.
  • the system provides ideal drug delivery for certain diseases relating to periodontics, tooth surface, endodontics, and diseases associated with cancer and medical conditions.
  • the system is placed so that release of the therapeutic agent occurs in the immediate vicinity of the disease process.
  • the volume of distribution is limited to the volume of gum pocket or crevice, relatively high concentrations of therapeutic agent can be delivered by devices with small therapeutic agent reservoir capacities.
  • the small amount of therapeutic agent required under these conditions typically a few milligrams, greatly reduces the effect of the therapeutic agent at distal sites within the body, thereby greatly decreasing the potential for systemic side effects.
  • a high degree of effectiveness is achieved using a relatively small amount of drug.
  • FIG. 1 shows an exemplary method for intra-oral delivery of a substance to an individual such as a patient, for example.
  • the substance can be a drug or a bio-active agent, among others.
  • the process of FIG. 1 includes attaching the substance to an oral structure ( 10 ) and allowing the substance to intra-orally interact with the body of the individual ( 12 ).
  • the substance is fluidly provided from the oral structure into the body at a predetermined rate.
  • the substance eventually affects or alters the individual's physiology in a desired manner ( 14 ).
  • oral structure refers to all areas within the mouth, including teeth, gingiva, cheeks, gums, lips, tongue, thorax, back of the throat, and beneath the tongue.
  • the method of FIG. 1 thus attaches the substance to an oral structure using a suitable dental device; and fluidly providing the substance from the oral structure into a body at a pre-selected dose.
  • the substance can accelerate or decelerate tooth movement.
  • the substance can induce irritation of the oral structure or can induce inflammation of a bone structure.
  • the pattern or sequence of irritation or inflammation can be varied. For example, the pressure, timing, location, degree of irritation or inflammation, and the depth of the irritation or inflammation can be varied.
  • the substance can be positioned on a bracket, a dental attachment, a bracket auxiliary, a ligature tie, a pin, a bracket slot cap, a wire, a screw, a micro-staple, a denture, a partial denture, a dental implant, a periodontal probe, a periodontal chip, a film, or a space between teeth.
  • the substance can also be positioned on a removable appliance, and one or more modules may be positioned on the removable appliance to house the substance.
  • the substance can provide energy for treatment, for example electric, light, heat, sound, magnetic or electromagnetic energy.
  • the oral structure can be recharged with an additional amount of the same or different substance.
  • the physical volume or shape of the substance is computer designed to support a precise delivery of the substance.
  • a computer system can scan a patient's dentition; and design one or more appliances to attach the substance to the oral structure based on the scanned dentition. At least one of the appliances is designed to dispense the preselected dose. Moreover, the appliances can dispense the substance in a predetermined sequence. For example, at least two of the appliances can dispense the substance in two different dosages for delivery at two different periods. Thus, for birth control drugs, more can be delivered on day 15 and less can be delivered on day 30, for example.
  • the system can perform diagnostics as well. To do this, the system samples an intra-oral substance; and detects a body condition (such as a disease) based on the intra-oral substance.
  • a processor can receive the sampling result and performs a close-loop delivery of substance based on a sampled intra-oral substance, as discussed in more detail below.
  • the system can also transmit the detected body condition to a remote computer for diagnosis.
  • the substance can be any known chemical substance.
  • the substance is a medical grade drug, chemical agent, or a bioactive agent.
  • the drug or agent can include antibacterials, antibiotics, anti-inflammatory agents, immune-suppressive agents, immune-stimulatory agents, dentinal desensitizers, odor masking agents, immune reagents, anesthetics, nutritional agents, antioxidants, lipopolysaccharide complexing agents, and peroxides, among others.
  • the attachment of the substance to the oral structure can be done through a removable appliance, a fixed appliance such as a bracket, a dental attachment, a wire, a screw, a tap, a micro-staple, a dental implant, a perioprobe, a periochip, a film or composite material, or a space between teeth, among others.
  • a removable appliance such as a bracket, a dental attachment, a wire, a screw, a tap, a micro-staple, a dental implant, a perioprobe, a periochip, a film or composite material, or a space between teeth, among others.
  • the tooth is held firmly in place by the cementum, periodontal ligament, alveolar bone and gingiva.
  • These connective tissue structures contain collagen and elastin fibers crosslinked into a supporting matrix. Additional components of this matrix include glycosaminoglycans (GAGs) and proteoglycans which play a role in resisting compressive forces in tissues.
  • GAGs glycosaminoglycans
  • proteoglycans which play a role in resisting compressive forces in tissues.
  • the architecture of this matrix can shift over time in response to a constant pressure that stimulates matrix breakdown, matrix resynthesis and remodeling of the tissue. To accelerate tooth movement, agents increase the rate of matrix degradation during the period in which force is applied to the tooth.
  • FIG. 2A shows an exemplary removable appliance 15 adapted to fit over teeth on a jaw 16 .
  • the appliance can be coated with a drug, chemical agent, or a bioactive agent.
  • the drug is inactive until contact with water or saliva.
  • release of the agent can be stimulated by water or by saliva.
  • saliva upon wearing, saliva activates the drug/agent and allows the drug/agent to seep out and treat the patient through the oral cavity of the patient.
  • the substance can also be delivered through the patient's gingiva.
  • the appliance can release the agent to the oral environment when the appliance is placed over the teeth.
  • Such means may comprise a layer which includes the agent.
  • the layer may be formed over at least a portion of the surfaces of the repositioning appliance. These surfaces include both the cavity surfaces, the surfaces within the cavities which contact the teeth when in place, and the external surfaces, the surfaces of the appliance which contact the cheeks and lips when in place.
  • the layer may be comprised of various materials and may take a variety of forms.
  • the layer may consist essentially of the agent.
  • the agent may be attached directly to a surface of the polymer shell of an elastic repositioning appliance.
  • This may be achieved by applying the agent (optionally in an inert carrier or diluent) itself to the surface utilizing a number of methods, such as spraying, painting and/or dipping.
  • the agent may then be released to the oral environment.
  • the layer may comprise the agent present in or on a carrier or binder which promotes adhesion or attachment to the appliance and/or which creates a matrix from which the agent can be released by diffusion or dissolution.
  • the agent is dissolved in the carrier or binder.
  • the agent may be provided in powder or similar form and dissolved in a liquid solvent. The result may be a solution which may be applied to a surface of the shell, typically by spraying, painting and/or dipping, to form a coating or film.
  • the agent may then be released from the coating to the oral environment. Release may be due to activation or deactivation of the carrier or any other releasing mechanism, such as by enzymes or proteins in saliva.
  • Or release may be due to degradation of the carrier by contact with, for example, saliva.
  • the binder or carrier may evaporate upon application to the layer to the surface leaving the agent behind.
  • the agent may be released in a similar fashion as when the agent is directly attached to the surface, as described above. It may be appreciated that any agent, particularly fluoride materials, antibiotics, bleaching materials and breath fresheners, may be delivered to the oral environment in this manner.
  • the agent is encapsulated or suspended in the layer.
  • a common material for suspension of an agent is a semisolid material, such as a gel, jelly or putty. Such a material may be applied to a surface of the shell by spraying, painting and/or dipping to form a coating or film.
  • suspension is not limited to a scientific definition and may refer to any situation in which a carrier holds, contains, supports or otherwise includes an agent.
  • the semisolid material may be deposited in the cavities of the polymer shell which are shaped to receive the teeth. The cavities may be filled to any desired level.
  • the teeth When the repositioning appliance is positioned over the teeth, the teeth will directly contact the semisolid material in the cavities and displace any extra material as the teeth are inserted into the cavities. Therefore, it is desired to fill the cavities to a level which will avoid excess overflow of the material from the appliance. Delivery of an agent by use of a semisolid suspension material is common in bleaching treatments and fluoride treatments, for example. However, such treatments apply the material with the use of a tray or generic appliance which does not apply repositioning forces to the teeth. By modifying a repositioning appliance, as described above, orthodontic treatment may continue throughout the delivery of such agents. It may be appreciated that any agent, particularly fluoride materials, antibiotics, bleaching materials and breath fresheners, may be delivered to the oral environment in this manner.
  • the layer may be comprised of a rate-controlling material wherein the rate controlling material controls the rate at which the agent is released from the layer.
  • Controlled-release or rate-controlled materials deliver a predetermined amount of an agent at a predetermined rate. Often such delivery maintains a steady-state concentration of an agent in an environment within a desired therapeutic range for a prolonged period of time. Thus, a prescribed dosage may be delivered.
  • the ability to sustain delivery eliminates the need for repeated applications of the agent for dosed delivery to the oral environment.
  • controlled release materials may be provided as a semisolid material, such as a gel, jelly or putty, as described above, these materials may also be provided as a solid material which is attached to the polymeric shell of the repositioning appliance.
  • One type of controlled-release material comprises a polymer matrix membrane within which finely dispersed particles of an agent are suspended. The agent may diffuse through the matrix membrane according to a concentration gradient. Alternatively or in addition, the agent may be released by degradation of the polymer matrix membrane material. In either case, the controlled-release material may be provided as a sheet which may be laminated to a surface of the shell. The controlled-release sheet may be layered with the elastomeric polymer and vacuum formed over a mold to form the repositioning appliance.
  • the controlled-release material may be arranged so that it is present on the inside or outside surfaces of the appliance depending on the material and desired application.
  • the controlled-release sheet may be laminated or bonded to a surface of the polymeric shell after forming to supply agent delivery in desired areas.
  • the controlled-release material may be provided as a tablet or similar mass which may be inserted into the polymeric shell of the repositioning appliance. The agent may then elute from the tablet into the oral environment over time.
  • the agent may be held within pores of a material and may elute out at a controlled rate from the pores.
  • the agent itself may be absorbed into the pores of the material, or the agent may be suspended in a carrier which is absorbed into the pores of the material.
  • the agent may be released from the carrier by diffusion and/or by controlled degradation of the carrier material. This may incorporate a rate-controlling mechanism in addition to the controlled-release of the agent from the pores.
  • enzymes in the patient's saliva will activate the release or degrade the carrier material to release the agent. It may be appreciated that the agent may be released by a combination of any of the release methods.
  • the polymeric shell of the repositioning appliance itself comprises a controlled-release material containing the agent.
  • a controlled release material wherein the rate controlling material controls the rate at which the agent is released from the shell.
  • the controlled-release material may be a provided in the form of a sheet.
  • the sheet of controlled-release material may be vacuum formed over a mold of the patient's teeth to form a repositioning appliance itself. In this manner, no additional elastomeric materials may be needed to form the appliance.
  • the controlled-release material may be a polymer matrix membrane, a porous material or any suitable material. Controlled-release may be designed so that the elution rate of the agent corresponds to the repositioning rate of the teeth. The agent may elute throughout the repositioning process, concluding as the teeth reach the desired arrangement prescribed by the appliance.
  • the appliance is made from a polymeric material that exhibits reduced stress relaxation and creep when used as a tooth positioner in the oral cavity.
  • Tooth positioners are made from polymeric materials. Once fabricated the tooth positioners are coated with a thin layer of a polymeric material. This coating serves to protect the tooth positioner from the potentially harmful environmental effects of salivary components, water and temperature.
  • the physical properties of the polymeric coating e.g, durometer, lubricity, elasticity, etc.
  • substances may be combined with the polymeric coating solution to provide ancillary patient benefits. For example, flavorants may be combined with the polymeric coating and released over time to help control oral malodor.
  • Drugs to control gingivitis or treat periodontal disease may also be combined with the polymeric coating.
  • biocompatible dyes or colorants contained in the polymer matrix may be released when exposed to salivary fluids. The gradual disappearance of the colorant may signify whether or not the tooth positioner is being worn by the patient.
  • the polymeric coatings applied to the dental appliance serve as a protective barrier to the harmful effects of salivary components, temperature and water and can contain flavorants, dyes, polymers, surface active molecules, antimicrobial agents and drugs.
  • the releasing means coupled to at least some of the repositioning appliances comprises a reservoir formed in the shell of the appliance in addition to the cavity which receives the teeth.
  • a rate controlling membrane is disposed over the reservoir wherein the rate controlling membrane controls the rate at which the substance is released from the reservoir.
  • the reservoir may be pre-filled or pre-loaded with an agent or substance for delivery.
  • the appliance may be ready for insertion or use upon removal from any packaging without the need of loading the appliance with the agent for delivery. If the releasing means is designed for a single delivery period, the appliance may be worn throughout the prescribed repositioning period and then disposed of.
  • the reservoir may be replenished with the agent to be released any number of times throughout the prescribed repositioning period.
  • agent particularly fluoride materials, antibiotics, bleaching materials and breath fresheners, may be delivered to the oral environment in this manner.
  • a visual characteristic of the polymeric shell of an oral appliance may be desirable to change a visual characteristic of the polymeric shell of an oral appliance.
  • Such appliances comprise a polymeric shell having a cavity shaped to be removably placeable over the teeth and a material on or within the shell that changes a visual characteristic of the shell.
  • the visual characteristic is a color, such as green, red or blue.
  • the appliance may appear colored or a particular color under certain environmental conditions, either in the oral environment or when removed.
  • the described material may be a dye which changes color in response to a change in temperature.
  • the dye may change color when the appliance is removed from the mouth and changes temperature from body temperature (37° C.) to room temperature (25° C.).
  • the dye may change color when the appliance is rinsed with cool water.
  • the appliance can be used to provide an intra-oral drug delivery system.
  • drugs described above, other compounds can be used as well.
  • a drug coated appliance can be used to deliver desensitizing medication to sensitive teeth.
  • the drug substance can simply be a small amount of the active ingredient in a desensitizing toothpaste or gel, such as Sensodyne®.
  • the desensitizing agent is dispersed throughout the surface of the appliance and is delivered, at a substantially constant rate, to the patient's sensitive teeth for a relatively extended period of time.
  • appliances that are not pre-filled or pre-loaded may require loading prior or immediately prior to placing the appliance over the teeth.
  • Loading may comprise placing the agent in a teeth-receiving cavity. As described previously, the cavities may be filled to any desired level. When the appliance is positioned over the teeth, the teeth will directly contact the agent in the cavities as the teeth are inserted into the cavities.
  • loading may comprise placing the agent into an agent release reservoir in the appliance immediately prior to placing the appliance over the teeth. The agent will then elute from the reservoir into the oral environment when the appliance is in place over the teeth. The elution rate may be controlled by a controlled release membrane which separates the reservoir from the surrounding environment.
  • Loading may also comprise adhering a rate controlling material containing the agent to a surface of the appliance prior to placing the appliance over the teeth.
  • a rate controlling material may comprise a polymer matrix membrane which may be removably or permanently adhered to the polymeric shell of the appliance in desired areas for delivery of the agent.
  • loading may comprise absorbing the agent into a porous material on or within the appliance immediately prior to placing the appliance over the teeth.
  • Repositioning of the teeth with the use of a position adjustment appliance involves placing the appliance over the teeth. However, the appliance is periodically removed for daily dental hygiene practices and other events throughout the repositioning protocol until the teeth are moved to at least near the desired tooth arrangement. While the appliance is removed from the teeth, the appliance may be replenished with the agent or substance for delivery. Replenishment may be performed immediately prior to each time the appliance is replaced over the teeth or it may be performed according to any prescribed protocol.
  • a treatment plan is determined by an orthodontist or practitioner at the outset of orthodontic treatment.
  • the plan involves moving the teeth through a series of intermediate configurations or arrangements to a final desired arrangement with the use of a system of tooth positioning appliances.
  • Each appliance comprises a polymeric shell having cavities which is removably placeable over the teeth and wherein the cavities of successive shells are shaped to reposition teeth from one arrangement to a successive arrangement according to the treatment plan.
  • the entire series of appliances may be provided at the outset of treatment, or a subset of appliances.
  • the need or desire for delivery of an agent to the oral environment may occur at any point during the course of treatment.
  • an agent and/or means for releasing an agent to the oral environment may be coupled to an appliance at any time during treatment.
  • Means for releasing the agent may include a number of embodiments, including any such means previously described.
  • means for releasing the agent comprises a layer including the agent, as previously described, and coupling comprises adhering the layer to at least a portion of a surface of the appliance.
  • adhering may involve coating, spraying, dipping or painting the agent on the surface of the appliance.
  • a pre-formed appliance may simply be coated with the agent prior to insertion in the patient's mouth.
  • adhering may involve attaching the carrier or binder a surface of the appliance.
  • the agent is encapsulated in the layer, the layer may be attached to the surface of the appliance.
  • the layer may comprise a sheet of rate controlling material wherein the rate controlling material controls the rate at which the agent is released from the layer.
  • the sheet may be bonded to the surface of the appliance with an adhesive.
  • the sheet may be attached to the surface by press fitting.
  • the sheet and the surface may each be shaped so that they snap or fit together by pressing them together.
  • the sheet may have a formed protrusion and the surface a formed inset, wherein the protrusion fits into the inset when pressed upon the inset and holds the sheet in place.
  • the appliance may be porous or have a reservoir which can be loaded with a desired agent at any time the treating professional and/or the patient decide that it is appropriate.
  • an appliance can be immersed in a solution of the agent, allowing the appliance to absorb or adsorb the agent at a particular time.
  • the sheet may be pre-formed to a shape adapted for fitting against the surface of the appliance or a surface of the teeth or gingiva.
  • the sheet may be pre-formed to reflect the shape of the surface of one or more teeth or the gingiva, particularly along the gingival margin.
  • the preformed sheet may then be held against that surface when the sheet is coupled to the appliance and the appliance is placed over the teeth. Coupling may involve any means of attaching the sheet to the appliance.
  • the pre-formed sheet may further comprise an adhesive layer which may provide bonding of the sheet to the surface of the appliance.
  • the material to make the appliance of FIG. 2A can be supplemented with additional fillers such as electrically conducting fillers, magnetic fillers, illuminating fillers, piezoelectric fillers, and/or light sensitive fillers.
  • additional fillers such as electrically conducting fillers, magnetic fillers, illuminating fillers, piezoelectric fillers, and/or light sensitive fillers.
  • the material properties of the appliance made with or without these additional fillers such as modulus, electrical resistance, material permeability, and birefringence (degree of orientation of the material or stress), illuminating patterns or patterns under special light sources may change after the appliance is worn over time, as these properties are altered due to changes in structure, organization, and/or spatial spacing between the fillers. For example, it is well established that electrical conductivity of filled composites scales with filler volume concentration according to percolation theory.
  • electrically conductive fillers include metals, graphite, electrically conductive polymers, semiconductors, and superconductors. These changes in properties can be used as an indicator for compliance and can be diagnosed by instrumentation. Similarly, separation of conductive fillers will also lower thermal conductivity, which can also be measured by instrumentations. If the fillers have magnetic behavior in the presence of external stimulation, such as diamagnetics (Cu, Au, Ag, etc.) and paramagnetics (e.g.
  • FIG. 2B shows a second embodiment of FIG. 2A .
  • an appliance 17 has a plurality of delivery nozzles 18 A- 18 C that project from the appliance 17 to contact the patient's gum tissue on the side of the gum or in a periodontal pocket.
  • the nozzles 18 A- 18 C can be on either the frontal side, the lingual side, or both sides of the teeth on the jaw 16 .
  • one or more reservoirs 19 A- 19 C can store extra drug/agent for delivery through nozzles 18 A- 18 C.
  • reservoirs 19 A, 19 B, and 19 C can contain the same drug or substance.
  • reservoirs 19 A, 19 B, and 19 C can each contain a different drug/substance.
  • reservoir 19 A and 19 C can contain the same drug and reservoir 19 B can contain a different drug/substance.
  • the combination of drug storage as discussed above is illustrative only and any suitable combination for storing a plurality of drugs or substances in a plurality of reservoirs 19 A- 19 C can be used.
  • FIG. 2C shows a cross-sectional view of the appliance of FIG. 2B on an exemplary tooth.
  • the nozzle 18 A either stores the drug or agent or receives drug/agent from the reservoir 19 A.
  • the nozzle 18 A is adapted to be inserted into the gum of the patient to deliver the drug/agent to the patient.
  • FIG. 2D is a cross sectional view of FIG. 2C without the tooth and gum line.
  • FIG. 2E another embodiment of a drug/agent delivery device is shown.
  • a plurality of drug/agent containers or modules 23 are positioned in an inside lining of a removable dental appliance 21 .
  • the appliance 21 is fitted over a tooth 25 .
  • the appliance 21 carrying the modules 23 is pressed toward the tooth 25 .
  • one or more of the modules 23 burst, releasing the drug or agent into the oral cavity.
  • the modules 23 can also be positioned on an outside lining of the appliance 21 as well.
  • FIG. 2F yet another embodiment of a drug or agent delivery device is shown.
  • an attachment 27 is mounted on a tooth 25 .
  • the attachment contains a first material that is inactive absent the presence of a second material.
  • the second material is coated on an appliance 29 and is also inactive in the absence of the first material.
  • the appliance 29 is worn over the tooth 25 and the attachment 27 , the first and second materials react to form a drug or an agent suitable for intra-oral delivery.
  • brackets and wires are used to effect tooth positioning as well as drug delivery.
  • a base 20 and a plurality of brackets 24 are positioned on the teeth.
  • a wire 28 is positioned in the slots of the brackets 24 .
  • the base 20 and the brackets 24 contain drug/agent to treat the patient.
  • the fixed appliances can be mounted on the lingual side of the teeth as well.
  • a base 30 and a plurality of brackets 34 are placed on the rear or lingual side of the teeth, and a wire 38 links the base and brackets for orthodontic treatment and drug delivery.
  • the drug/agent can be delivered using bases and brackets and wires on both sides of the teeth such as that shown in FIG. 3 .
  • FIG. 4A shows a cross-sectional view while FIG. 4B shows a perspective view of a bracket with a reservoir.
  • a bracket body 42 has a base region 46 and a slot 47 to receive a wire (not shown).
  • a reservoir 44 that contains drugs or agents for delivery to the patient.
  • the bracket body 42 and reservoir 44 can be of any suitable metal, or can be of a translucent or transparent plastic material or any suitable biocompatible metal. These general types of materials are commonly used in the practice of orthodontic care. It should be understood that the size and shape of the bracket body 42 and reservoir 44 are not critical and the exemplary bracket is described for purposes of illustration.
  • FIG. 4C shows another embodiment where the substance can be stored in a cap 48 that is received by the slot 47 .
  • the cap 48 can be used with a conventional bracket without the reservoir 44 as well as with the bracket of FIG. 4A .
  • the substance in the cap can be the same as the substance in the reservoir 44 or can be different from the substance stored in the reservoir 44 .
  • FIG. 4D shows yet another embodiment where the substance can be stored in a band 52 that encircles the slot 47 .
  • the band 52 can be used with a conventional bracket without the reservoir 44 as well as with the bracket of FIG. 4A .
  • the substance in the band 52 can be the same as the substance in the reservoir 44 or can be different from the substance stored in the reservoir 44 .
  • the band 52 can receive a substance from a band reservoir 54 .
  • FIG. 4E shows yet another embodiment with a bracket 56 that has an opening 57 extending from one side of the bracket 56 to the other side of the bracket 56 .
  • a substance is provided in a housing 58 which can be ball-shaped or box-shaped, among others.
  • a wire 59 is attached to the housing 58 and the wire 59 can be threaded through the opening 57 . After reaching the other side of the bracket 56 , the wire can be twisted or bent or otherwise secured to the bracket 56 , as shown by a bent wire 59 A. The bent wire secures the housing 58 to the bracket 56 for delivery of substances to the patient.
  • FIG. 5A shows another embodiment where a second reservoir is mounted on a second side of the teeth opposite to the side where the bracket of FIG. 4A is mounted.
  • a second reservoir 50 contains additional drugs or agents.
  • the second reservoir 50 is connected to the reservoir 44 through a pipe 52 to replenish the drug or agent as needed.
  • the reservoirs 44 or 50 can be recharged using a needle to inject additional drug/agent to the reservoirs.
  • the reservoir 44 or 50 can be replaceable to replenish the drug/agent.
  • FIG. 5B shows another embodiment where a bracket 64 is used as a mount or support for a drug/agent housing 66 on a tooth 60 .
  • the housing 66 abuts the gum or a surface of the oral cavity to expedite delivery of drug/agent to the patient's body.
  • FIG. 5C shows another embodiment where the bracket 64 is used as a mount or support for a drug/agent housing 68 on the tooth 60 .
  • the housing 68 is spaced apart from the gum or a surface of the oral cavity to delivery drug/agent to the patient's body.
  • FIG. 5D shows yet another embodiment for delivery of drug or therapeutic agent.
  • a permeable implant 70 is mounted on the patient's gum 71 .
  • a post or abutment 73 with a screw or threaded end 72 is mounted on the implant 70 .
  • a crown-shaped housing 74 contains a drug or agent that seeps or permeates through the abutment 73 and the implant 70 to be delivered to the patient's body.
  • FIG. 5E shows a screw embodiment where drug or agent is embedded in a screw having a head 76 and a threaded portion 75 .
  • the screw is tapped into the patient's gum where it delivers the drug or agent into the patient's body.
  • micro-staples can be used to deliver drugs to the body.
  • dentures and partial dentures can have drug(s) or agent(s) embedded therein to deliver drug to the patient's oral cavity or body.
  • the drugs or agents can be embedded in spaces between teeth.
  • FIG. 6A shows another embodiment where energy is applied to an appliance 78 to affect teeth movement or drug delivery.
  • electricity is stored in an energy source 83 such as a battery.
  • a switch 81 is used to deliver energy to the oral cavity.
  • the switch 81 is controlled by electronics 79 such as a microcontroller.
  • the electronics 79 delivers a predetermined amount of energy to treat the patient or to deliver drug.
  • FIG. 6B shows another embodiment where energy is applied to wires 80 and 82 to effect teeth movement or drug delivery.
  • electricity is stored in an energy source 88 such as a battery.
  • a switch 84 is used to deliver energy to the oral cavity through wires 80 and 82 .
  • the switch 84 is controlled by electronics 86 such as a microcontroller.
  • the electronics 86 delivers a predetermined amount of energy to treat the patient.
  • the energy in one instance can be low-level electrical current to promote healing at the bone level.
  • the energy source 88 is connected through switch 84 to a material such as nichrome, the energy can be low level heat.
  • the energy source 88 is connected through switch 84 to a light emitting diode (LED)
  • the energy can be light and when the LED is in a lasing mode, the energy can be a laser beam.
  • the energy can be a magnetic field in another instance where the energy source 88 is connected through switch 84 to an inductor.
  • Ultra-sound can be used as well where the energy source 88 is connected through switch 84 to an ultrasound vibratory source or transducer.
  • the transducers can be electronically activated to vibrate and emit ultrasonic pulses to promote bone healing. In addition to healing the bone, some of the pulses penetrate the tooth and are returned to other transducers on a sensor array.
  • These echo or reflected pulse signals after being detected by transducers on the array, can be collected, analyzed and compared to produce a recreation of the tooth or dental structure being examined. By collecting reflected or scattered signals from as many angles as possible, the electronics will have sufficient time-of-flight measurements to perform a tomographic computation to model or map the tooth volume.
  • Vibrations can be used to inflame or irritate the bone structures to promote tooth movement as well.
  • the appliance is coated with a material that can expand and contract upon receipt of an electrical stimulus.
  • Electroactive polymer composites fabricated from an organic filler possessing very high dielectric constant dispersed in an electrostrictive polymer matrix, can be used as dental actuators.
  • the composite can have a matrix made from electrostrictive poly(vinylidene fluoride-trifluoroethylene), an electroactive copolymer and a filler such as an organic semiconductor, copper-phthalocyanine.
  • the composite acts as artificial muscles. Upon actuation, they can repetitively contract and expand to create vibrations on the teeth to encourage teeth movement.
  • memory-materials such as nitinol can be used and the contraction/expansion can be controlled.
  • Heat, electrical, or microwave energy can be used on other materials to induce them to change state and to inflame or stress the bone/gum structure to induce teeth movement.
  • a wire in another embodiment, can be attached directly to the teeth or indirectly to the teeth using a removable appliance and the wire can be repetitively wound and unwound using a micro-motor. Such repetitive movements apply stress that inflame or irritate the gum or bone structure to enhance teeth movement.
  • FIGS. 6A-6B show that the substance (in this case battery 83 or 88 ) provides energy to the oral cavity.
  • the energy can be physical, electric, light, heat, sound, magnetic or electromagnetic energy.
  • the devices of FIGS. 6A-6B can be used to irritate or inflame the oral structure.
  • the devices can be used to inflame gingival or the bone structure of the teeth to encourage teeth repositioning.
  • the appliances can be used to enhance drug delivery by using electrical current to induce drug movement.
  • the drug molecules can be transported between one electrical pole to another electrical pole.
  • Another implementation provides a positive current on one side of the appliance, and a negative current on the other side of the appliance to force the drug through the gum or dental tissue.
  • the appliance induces a change in the polarity of the teeth.
  • the tooth is normally negatively charged and the drug in the appliance is positively charged. Opposite charges attract and bond to each other and the drug or agent can be attached to the tooth surface by “ionic bonding”.
  • the appliance containing drug can be configured so that positively charged ions are transferred to the teeth.
  • the tooth polarity changes from negative to positive.
  • the positively charged tooth ions repel the positively charged ions from other substances. For example, plaque ions are repelled from tooth ions such that plaque can be removed from the oral cavity.
  • the appliance applies submucosal iontophoresis to accelerate tooth movement.
  • lontophoresis stimulates osteoclasts in the periodontal pression side and osteoblasts in the tension side.
  • the substance accelerates tooth movement by degrading the matrix.
  • Matrix degradation can be stimulated either directly or indirectly.
  • Chemical agents may act as enzymes to directly breakdown structural proteins in the matrix. Proteases degrade protein, elastases degrade elastin, collagenase degrades collagen, among others. Other drugs or hormones such as relaxin, estrogen, or nicotine may act on cells within the matrix and cause those cells to secrete endogenous matrix degrading enzymes.
  • MMPs matrix metalloproteases
  • MMPs matrix metalloproteases
  • MMPs matrix metalloproteases
  • a large number of drugs have been developed to prevent matrix breakdown. These drugs are typically useful as anti-inflammatory agents or anti-cancer therapies. Some of these candidates have been used to prevent or treat periodontitis. A very few drugs are available to stimulate matrix breakdown and those are commonly used for indications like wound debridement, breakdown of blood clots, or stimulating gastrointestinal digestion. Their utility in the setting of orthodontic remodeling would need to be tested in appropriate preclinical models.
  • One exemplary drug can be Granulex or Xenaderm.TM whose active ingredient is trypsin. This drug is indicated for wound debridement, wound healing, or varicose vein treatment. This ingredient breaks down many different types of protein.
  • another active ingredient such as hyaluronidase can be used to degrade hyaluronan which is thought to have a role in resisting compressive forces in tissue.
  • elastase can be used to degrade elastin preferentially and may help to both accelerate remodeling and prevent relapse.
  • Another exemplary drug can be Alteplase or Activase® whose active ingredient is tissue plasminogen activator. These drugs are indicated for thrombolytic therapy. In the presence of a thrombus Activase binds to fibrin and converts plasminogen to plasmin to stimulate fibrinolysis. These drugs may only work in the context of blood clots.
  • Examples of other exemplary drugs are Arco-Lase®, Creon®, Kutrase®, Kuzyme®, Ultrase®, and Viocase®, whose activity depends on a combination of enzymes: amylolytic, proteolytic, celluloytic and lipase. These drugs are indicated for the treatment of gastrointestinal disorders due to poor digestion.
  • the drug, Arco-Lase comes in soft, mint flavored tablets. All these drugs warn that they may irritate oral mucosa, which may be an indication that they could work to soften gum tissue as well as degrade food proteins.
  • Examples of other exemplary drugs are Accuzyme®, Gladase®, and Panafil® whose active ingredient is papain. This drug is indicated for treatment of wound debridement. Papain combined with urea dissolves non-viable protein but supposedly leaves viable tissue intact.
  • Another exemplary drug can be Potaba® whose active ingredient is aminobenzoate potassium. This drug is indicated for antifibrosis therapy for scleroderma, Peyronie's disease, dermatomyositis and morphea. This ingredient is part of the vitamin B complex and is reported to soften tissue with long term use.
  • Another exemplary drug can be Aldurazyme® or Laronidase, whose active ingredient is alpha-L-iduronidase. This drug is indicated for treatment of mucopolysaccharidosis. This ingredient is a lysosomal hydrolase that breaks down the glycosaminoglycans: dermatin sulfate and heparan sulfate.
  • Elastase enzymes are produced by a number of inflammatory cells for example neutrophil elastase, leukocyte elastase, granulocyte elastase or macrophage elastase (which is also called MMP-12). As described below, agents or activities that stimulate inflammation, cause an increase in the local concentration of these inflammatory cells and therefore an increase in the local concentration of elastase enzymes.
  • Hyaluronidase is an enzyme found in mucous membranes that specifically degrades hyaluronic acid which is part of the glycosaminoglycan matrix molecules important for resisting compressive force.
  • the cathepsin family of lysosomal enzymes is a large and varied family of cystein proteases important in many disease processes that involve tissue disruption.
  • Cathepsin B for example, is known to play a role in demyelination, emphysema, rheumatoid arthritis and neoplastic infiltration.
  • Cathepsin B is also known to be elevated in gingival crevicular fluid during orthodontic tooth movement and is thought to be involved in extracellular matrix degradation in response to mechanical stress.
  • Another cathepsin, cathepsin K is upregulated in odontoclasts and osteoclasts during tooth movement and may play a role in root resorption during this process.
  • any enzyme that is capable of breaking down a component of the gingival extracellular matrix is capable of accelerating tooth movement.
  • An alternative means to disrupt the tissue matrix is by addition of compounds that can interfere with the normal interaction between different components of the matrix architecture.
  • integrins serve to link cells to the extracellular matrix.
  • Addition of a class of agents known as disintegrins can block this interaction and loosen the connective structure of the matrix.
  • Disintegrins are found in snake venoms and are useful to this species because of their ability to facilitate tissue penetration of the venom.
  • Disintegrins found in many snake species are called variously albolabrin, applagin, batroxostatin, bitistatin, echistatin, elegantin, flavoridin, halysin, kistrin, triflavin, and trigramin.
  • Primary constituents of the extracellular matrix are collagen, elastin, fibronectin, laminin, integrins, proteoglycans and glycosaminoglycans. Additional constituents are fibrillin, versican, link protein, entactin, tenascin, vitronectin, decorin, cadherin and many others. Many of these components bind to one another to add rigidity and structural integrity to the tissue matrix architecture. Often these interactions are through specific binding sites involving an RGD (arginine-glycine-aspartate) peptide sequence. Antibodies or other binding agents that target these binding sites are capable of disrupting matrix integrity and loosening the tissue.
  • RGD arginine-glycine-aspartate
  • Antibodies or other binding agents will be effective if they have an affinity for the binding sites that is greater than that of the native proteins.
  • One means of generating a large number of agents capable of binding at, for example, an RGD site is by screening with phage display peptide libraries such as described in Odermatt et al.
  • Tissue extracellular matrix degradation may be brought about by direct application of enzymes and binding agents as described above, or through indirect means by addition of agents that stimulate the overexpression of endogenous enzymes.
  • An example of this type of agent includes drugs that alter the expression or activity of matrix metalloproteases (MMPs).
  • MMPs are a family of structurally related, protein-degrading enzymes that require calcium ions for structural conformation and zinc ions in their active site for function.
  • the MMP enzymes can be administered either alone or in combination to directly impact tissue degradation.
  • MMP-1, MMP-2, MMP-3, MMP-8 and MMP-9 are the matrix degrading enzymes known to be active in the periodontal space.
  • Matrix metalloproteases are also known as matrix metalloproteinases, collagenases, gelatinases, or CLGs.
  • MMP-2 is also called collagenase type 4 (A), gelatinase A, or CLG 4 (A).
  • Some MMPs are known by additional names due to the fact that their discovery preceded knowledge of the family characteristics.
  • MMP-3 is also known as stromelysin-1 or transin. The MMP enzymes listed above have been purified and are available commercially.
  • MMP family of enzymes is capable of digesting almost all of the components of the extracellular matrix. They often work best in concert whereby an MMP isotype with selective collagenase activity will cleave the type I collagen triple helix allowing access to additional MMP enzymes which then further degrade the protein.
  • MMP-3 in contrast to MMP-1 and MMP-2 does not break down type I collagen but can degrade proteoglycan and fibronectin which are other important constituents of the extracellular matrix.
  • TMPs tissue inhibitors of metalloproteases
  • An exemplary drug that may work to accelerate tooth movement by stimulation of endogenous MMP activity is Prepidil® (dinoprostone) whose active ingredient is prostaglandin E2. This drug is indicated for treatment of induction of labor. Prostaglandin E2 has been shown to enhance MMP-1 (collagenase) and sometimes MMP-3 (stromelysin) expression in human gingival tissue. Another exemplary drug that contains the same active ingredient is Prostin E2® which is indicated for termination of pregnancy.
  • Another exemplary drug can be Fluprostenol.
  • This drug is a potent luteolytic agent with prostaglandin F2alpha activity. Research shows that it can increase MMP-1 production and degrade connective tissue in human gingiva.
  • Nicoderm® can be Nicoderm®, Commit® and Nicorette®, whose active ingredient is nicotine. This drug is indicated for treatment of smoking cessation. This ingredient has many effects such as vasodilation, but research shows it can increase collagenase activity and matrix turnover in gingival tissue.
  • keratinocyte-derived collagenase stimulatory factor also known as stratifin. Delivery of this agent can cause upregulation of collagenase enzymes in fibroblasts present in gingival tissue.
  • An even more direct way to stimulate overexpression of matrix degrading enzymes is to use gene therapy techniques to either transfect local cells with constructs encoding these enzymes or with enhancer or promoter elements capable of stimulating endogenous gene transcription of those particular enzymes. For example, overexpression of manganese superoxide dismutase is known to cause activation of MMP-2.
  • Agents that elevate the intracellular concentration of cyclic adenosine monophosphate (cAMP) are also capable of promoting MMP-2 overexpression, increasing the activity of this enzyme and decreasing collagen content in tissue.
  • agents with this capability are isoproterenol, prostaglandin E2 and forskolin.
  • Relaxin is another agent that is capable of enhancing MMP-2 production.
  • Cytokines are agents usually secreted by cells to bring about a response in another cell. Thus, they are important in cell to cell communication.
  • a number of common inflammatory cytokines have been elucidated and many more are likely to be discovered and characterized in the future. Inflammatory cytokines are released after injury and help to recruit additional inflammatory cells into the area of tissue damage.
  • Orthodontic tooth movement usually involves a mild inflammatory response. If exacerbated, this inflammatory response will likely promote additional tissue degradation and may speed the process of tooth movement.
  • the most commonly known inflammatory cytokines are interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF ⁇ ) and transforming growth factor-beta (TGF- ⁇ ).
  • Inflammation can be brought about by virtually any means of causing local tissue damage. Mechanical force such as pushing, pulling or stretching the tissue can trigger release of local pro-inflammatory cytokines. Tearing or abrasion of either soft tissue or bone can similarly trigger an inflammatory reaction. Addition of an irritant such as a powder, polymer, or any type of foreign body can incite inflammation. Alteration of local pH into either an acidic or basic range beyond normal physiological pH can cause inflammation. Elevated temperature can have a similar effect as can the addition of other energy sources such as ultrasound, or electrical energy.
  • the drug or bioactive agent assists in a “retention” phase, without which there is a tendency for the teeth to return to their initial position (relapse).
  • the underlying cause for this relapse appears to reside in the gingival tissue which, unlike bone and the PDL, is not resorbed during orthodontic treatment but is compressed and consequently retracts.
  • On the pressure aspect of the gingiva there is an increase in the number and size of elastic fibers and an increase in collagen.
  • the elastic forces stored in the compressed gingiva can exert pressure on the tooth and cause relapse after the release of retention. Procedures such as gingival circumferential fiberotomy have been introduced to disconnect the compressed gingiva from the tooth and have demonstrated some success in preventing tooth relapse.
  • Bioactive agents can accelerate tooth movement.
  • the bioactive agents described above work primarily by enhancing collagen or elastin degradation. If delivered to the appropriate local tissue bed these agents should, then, limit the increase in collagen and elastin accumulation on the pressure side of the gingiva and reduce the tendency to relapse. There are, however, other mechanisms to prevent tooth relapse.
  • One way to chemically stabilize tooth position after completion of the orthodontic movement involves increasing the number of chemical crosslinks between collagen fibers, particularly on the tension aspect of the tooth. Increased crosslinking provides more structural stability to the new fiber orientation in the gingival tissue.
  • Formaldehyde and glutaraldehyde are the most well known agents capable of crosslinking collagen and these agents are commonly used to treat bioprosthetic tissue prior to use of that tissue as a medical implant. Standard formulations of formaldehyde and glutaraldehyde are likely too toxic to be used in situ, but may be modified to reduce their tissue toxicity.
  • Chemical crosslinking agents can be used to crosslink extracellular matrix components for many different indications.
  • Genipin is a relatively non-toxic, naturally occurring crosslinking agent that can be used.
  • Carbodiimide is considered to be a somewhat less toxic crosslinking agent, though at least one study showed that genipin was better able to stimulate intermolecular collagen crosslinks compared to carbodiimide. Intermolecular rather than intrahelical crosslinks are more likely to bring about the desired tissue stabilization.
  • 1,6-diaminohexane (DAH) is also an effective collagen crosslinking agent that has been shown to be slightly less toxic than cardodiimide especially in the presence of glycosaminoglycans (which are naturally occurring in gingival tissue).
  • Dimethyl 3,3′-dithiobispropionimidate is yet another example of a crosslinking agent reported to be more biocompatible than standard agents like glutaraldehyde
  • AGEs advanced glycation endproducts
  • AGEs accumulate over the course of a person's lifespan and a number of detrimental conditions have been attributed to this accumulation including increased vascular and myocardial stiffness, endothelial dysfunction, altered vascular injury responses and atherosclerotic plaque formation.
  • increased crosslinking for a limited period of time could prove beneficial and these agents are relatively simple sugars not associated with any additional toxicity. Acceleration of AGE-related crosslinking can be brought about by increasing the concentration of reducing sugars and also by application of external energy such as UV irradiation.
  • bioflavonoids is another broad class of compounds that could prove very useful in this endeavor. They are exemplified by molecules such as riboflavin, catechin and rutosides. Many of these compounds are found naturally in food substances like red wine and green tea. They tend to be very biocompatible but are also known to promote the crosslinking of collagen either alone or in combination with adjunctive energy like UV-A or rose Bengal/white-light irradiation. In the case of riboflavin-UVA, this treatment has been used clinically to promote collagen crosslinking of the sclera to increase its biomechanical strength for the treatment of progressive myopia.
  • the substance can be anesthetics and analgesics such as benzocaine, lidocaine and prilocaine, among others, that are locally released through the appliance.
  • analgesics such as benzocaine, lidocaine and prilocaine, among others, that are locally released through the appliance.
  • the drug can be nicotine to relieve patient discomfort or to treat another disease.
  • tobacco donor tobacco
  • a receiving substrate on the appliance which has been treated with a strong acid or an ammonium salt of a strong acid.
  • Part of the nicotine in the donor tobacco is transferred from the donor tobacco to the receiving substrate. Thereafter the donor tobacco and the substrate may be separated.
  • the donor tobacco has a reduced nicotine content for pain relief or medical treatment.
  • the appliance can be used to provide a local release of breath fresheners such as menthol, peppermints, spearmints, wintergreen, zinc gluconate, citrus, clove and thymol, among others, that may promote patient compliance to facilitate treatment. More breath freshener information is shown in US Patent Publication No. 20040115137, the content of which is incorporated by reference.
  • the substance can prevent tooth decay through fluoride treatment.
  • Treatments include toothpastes, gels, rinses and varnishes.
  • Gum disease such as gingivitis or periodontitis, is caused by bacterial growth associated with dental plaque and calculus deposits. The most common recommendation for preventing such bacterial growth is to mechanically remove the plaque from the tooth surfaces.
  • chronic gingivitis and tooth decay have plagued many individuals who in fact comply with good oral hygiene methods and plaque removal. This may be due to a variety of factors including genetic predispositions, illnesses, mouth breathing, and medical treatment programs. In such cases, bacterial control may be accomplished with the use of antibacterial drugs.
  • a common antibacterial agent shown to be effective in reducing the activity of many common strains of oral flora is chlorhexidine.
  • Chlorhexidine is a cationic biguanide microbicide with a broad spectrum of activity against many forms of bacteria and fungi. Therefore, it has been a popular agent in many studies of gingivitis reversal. Chlorhexidine has traditionally been delivered to the oral environment through the use of rinses, such as Peridex® (Proctor and Gamble). Sustained delivery to the gingiva has also been attempted with the use of chlorhexidine impregnated dental floss and dental appliances, such as trays or mouthguards. Another frequently prescribed antibacterial agent is tetracycline. Tetracycline is a broad spectrum antibiotic which is effective against virtually all common groups of pathogenic bacteria, both gram positive and negative.
  • Tetracycline may be combined with an antifungal agent, such as amphotericin, to provide activity against fungi.
  • Tetracycline has traditionally been delivered to the oral environment through systemic administration, although localized delivery has been attempted with the insertion of tetracycline-filled hollow fiber devices into periodontal pockets and the use of tetracycline laden dental appliances, such as trays and mouthguards.
  • tetracycline laden dental appliances such as trays and mouthguards.
  • a number of other antibacterial drugs are available for dental and periodontal therapy.
  • Cosmetic treatments often include tooth bleaching or whitening and breath freshening products. Discolorations of enamel and dentin may occur due to aging, consumption of staining substances (coffee, tea, colas, tobacco), trauma, staining due to systemic tetracycline (antibiotic) therapy, excessive fluoride, nerve degeneration and old dental restorations. Bleaching lightens these discolorations for a whiter or brighter appearance. Typically, a bleaching gel is placed in a thin custom-fitted tray that fits over the teeth. The tray is worn at night for usually 10 to 14 days and may require periodic re-bleaching treatments for approximately one or two nights every six months. Breath freshening products are often used by patients to treat halitosis or for enjoyment of the taste. These include a variety of sprays, rinses, mints, gums, or candies, to name a few.
  • the substance can include chemicals that irritate the gum or bone.
  • the substance can inflame a bone.
  • the appliance used to deliver therapeutic or cosmetic agents to oral tissue can be easily adapted to deliver more than one agent and can also be adapted to deliver specific agents to select locations within the oral tissue.
  • a drug that accelerates collagen and/or elastin degradation might be delivered to the pressure aspect of the gingiva where there is typically an increase in the number and size of collagen and elastic fibers that oppose tooth movement.
  • the appliance might deliver an agent that promotes the crosslinking of collagen to the tension aspect of the gingiva to help stabilize the tooth movement achieved with the appliance.
  • reservoirs 19 A, 19 B, and 19 C can contain the same drug or substance.
  • reservoirs 19 A, 19 B, and 19 C can each contain a different drug/substance.
  • reservoir 19 A and 19 C can contain the same drug and reservoir 19 B can contain a different drug.
  • bleaching agents can be stored in one reservoir and delivered to the tooth itself while a second reservoir can store and deliver an agent capable of accelerating tooth movement to the gingiva surrounding the tooth.
  • different agents need not be delivered at the same time. It may be advantageous to deliver one agent at the beginning of orthodontic treatment and a different agent at another point during the treatment.
  • An example of this treatment regimen would be delivery of agents to accelerate tooth movement during the first weeks of orthodontia and delivery of agents to prevent tooth relapse following the period of tooth movement.
  • a buffering agent may be needed to alter the pH of a drug so as to make the therapeutic agent less caustic.
  • one agent to stabilize or activate the therapeutic agent once it has been released from the appliance.
  • An alternative exemplary case would be the use of more than one agent that have the same general effect as, for example, two agents that are likely to accelerate tooth movement. Two or more agents may be employed rather than one either because they will act synergistically by employing different modes of action to bring about an effect or because they have different unwanted side effects that can be reduced by lowing the dose delivered of each but maintaining a beneficial therapeutic effect because of the ability of the agents to work together in concert.
  • droplets can be used to deliver substances to the patient as well.
  • droplets can be sized within the range of about 1 to 200 microns and may be presented to the mucosa within a liquid, solid, or gaseous suspension, including an aerosol system which refers to a gaseous suspension of particles dispensed within the form of a mist.

Abstract

Systems and methods are disclosed for intra-oral delivery of drugs.

Description

    BACKGROUND
  • The present invention is related to systems and methods for intra-oral drug delivery.
  • As noted in commonly owned U.S. Pat. No. 6,607,382 entitled “Methods and systems for concurrent tooth repositioning and substance delivery,” the content of which is incorporated herewith, the repositioning of teeth may be accomplished with the use of a series of removable elastic positioning appliances such as the Invisalign® system available from Align Technology, Inc., the assignee of the present invention. Such appliances have a thin shell of elastic material that generally conforms to a patient's teeth but is slightly out of alignment with an initial or immediately prior tooth configuration. Placement of the elastic positioner over the teeth applies controlled forces in specific locations to gradually move the teeth into the new configuration. Repetition of this process with successive appliances comprising new configurations eventually moves the teeth through a series of intermediate configurations or alignment patterns to a final desired configuration. A full description of an exemplary elastic polymeric positioning appliance is described in U.S. Pat. No. 5,975,893, and in published PCT application WO 98/58596, the content of these documents are incorporated by reference for all purposes.
  • The appliance is effective in repositioning teeth when it is placed over the patient's teeth. Removal of the appliance for any reason interrupts the treatment plan and lengthens the overall period of treatment. Therefore, removal of the appliance should be minimized for effective and timely treatment. However, a number of dental and periodontal therapies which may be desired or required by the patient may not be effectively utilized while the appliance is in place. Such therapies may be prescribed by a practitioner to improve oral health or they may be requested by the patient for cosmetic purposes.
  • The '382 patent discloses devices, systems and methods for orthodontic treatment using elastic repositioning appliances while concurrently providing dental and periodontal therapies. Such therapies are traditionally provided with the use of a variety of accessories and devices which are applied when the repositioning appliance is removed from the patient's mouth. The '382 system eliminates the need for such removal and additional devices by incorporating these therapies into the repositioning appliance.
  • United States Patent Application 20040115587, the content of which is incorporated herewith, discloses an orthodontic treatment involving applying force to reposition teeth and administering a tissue remodeling and/or an angiogenic substance(s) to the periodontal tissue surrounding the teeth to be moved. The substance(s) may be delivered before, during, or after the teeth are moved, and the substance(s) may be selectively applied only to those teeth undergoing movement at any particular time. The substance(s) may be applied from the dental repositioning appliance or may be applied separately, either topically or by injection.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows an exemplary method for intra-oral delivery of a substance to an individual.
  • FIGS. 2A-2B are exemplary removable appliances adapted to fit over teeth on a jaw.
  • FIG. 2C shows a cross-sectional view of the appliance of FIG. 2B on an exemplary tooth.
  • FIG. 2D is a cross sectional view of FIG. 2C without the tooth and gum line.
  • FIGS. 2E-2F show additional embodiments of appliances for delivery of drugs or agents.
  • FIG. 3 illustrates another drug delivery system.
  • FIGS. 4A-4E illustrate various views of a bracket with a reservoir.
  • FIGS. 5A-5E show various embodiments of drug delivery systems.
  • FIG. 6A illustrates an embodiment where energy is applied to an appliance to effect teeth movement or drug delivery.
  • FIG. 6B illustrates an embodiment where energy is applied to wires to effect teeth movement or drug delivery.
  • SUMMARY
  • Systems and methods are disclosed for intra-oral delivery of drugs.
  • Advantages of the system include one or more of the following. The system enables drugs or therapeutic agents to be delivered through the mouth. The system provides ideal drug delivery for certain diseases relating to periodontics, tooth surface, endodontics, and diseases associated with cancer and medical conditions.
  • For dental diseases, the system is placed so that release of the therapeutic agent occurs in the immediate vicinity of the disease process. As the volume of distribution is limited to the volume of gum pocket or crevice, relatively high concentrations of therapeutic agent can be delivered by devices with small therapeutic agent reservoir capacities. The small amount of therapeutic agent required under these conditions, typically a few milligrams, greatly reduces the effect of the therapeutic agent at distal sites within the body, thereby greatly decreasing the potential for systemic side effects. Thus, a high degree of effectiveness is achieved using a relatively small amount of drug.
  • DESCRIPTION
  • Appliance for Drug Delivery
  • FIG. 1 shows an exemplary method for intra-oral delivery of a substance to an individual such as a patient, for example. The substance can be a drug or a bio-active agent, among others. The process of FIG. 1 includes attaching the substance to an oral structure (10) and allowing the substance to intra-orally interact with the body of the individual (12). In one embodiment, the substance is fluidly provided from the oral structure into the body at a predetermined rate. The substance eventually affects or alters the individual's physiology in a desired manner (14). The term “oral structure” refers to all areas within the mouth, including teeth, gingiva, cheeks, gums, lips, tongue, thorax, back of the throat, and beneath the tongue.
  • The method of FIG. 1 thus attaches the substance to an oral structure using a suitable dental device; and fluidly providing the substance from the oral structure into a body at a pre-selected dose. The substance can accelerate or decelerate tooth movement.
  • The substance can induce irritation of the oral structure or can induce inflammation of a bone structure. The pattern or sequence of irritation or inflammation can be varied. For example, the pressure, timing, location, degree of irritation or inflammation, and the depth of the irritation or inflammation can be varied.
  • The substance can be positioned on a bracket, a dental attachment, a bracket auxiliary, a ligature tie, a pin, a bracket slot cap, a wire, a screw, a micro-staple, a denture, a partial denture, a dental implant, a periodontal probe, a periodontal chip, a film, or a space between teeth. The substance can also be positioned on a removable appliance, and one or more modules may be positioned on the removable appliance to house the substance. The substance can provide energy for treatment, for example electric, light, heat, sound, magnetic or electromagnetic energy. The oral structure can be recharged with an additional amount of the same or different substance.
  • In one embodiment, the physical volume or shape of the substance is computer designed to support a precise delivery of the substance. A computer system can scan a patient's dentition; and design one or more appliances to attach the substance to the oral structure based on the scanned dentition. At least one of the appliances is designed to dispense the preselected dose. Moreover, the appliances can dispense the substance in a predetermined sequence. For example, at least two of the appliances can dispense the substance in two different dosages for delivery at two different periods. Thus, for birth control drugs, more can be delivered on day 15 and less can be delivered on day 30, for example.
  • The system can perform diagnostics as well. To do this, the system samples an intra-oral substance; and detects a body condition (such as a disease) based on the intra-oral substance. A processor can receive the sampling result and performs a close-loop delivery of substance based on a sampled intra-oral substance, as discussed in more detail below. The system can also transmit the detected body condition to a remote computer for diagnosis.
  • The substance can be any known chemical substance. Preferably, the substance is a medical grade drug, chemical agent, or a bioactive agent. Examples of the drug or agent can include antibacterials, antibiotics, anti-inflammatory agents, immune-suppressive agents, immune-stimulatory agents, dentinal desensitizers, odor masking agents, immune reagents, anesthetics, nutritional agents, antioxidants, lipopolysaccharide complexing agents, and peroxides, among others.
  • The attachment of the substance to the oral structure can be done through a removable appliance, a fixed appliance such as a bracket, a dental attachment, a wire, a screw, a tap, a micro-staple, a dental implant, a perioprobe, a periochip, a film or composite material, or a space between teeth, among others.
  • The tooth is held firmly in place by the cementum, periodontal ligament, alveolar bone and gingiva. These connective tissue structures contain collagen and elastin fibers crosslinked into a supporting matrix. Additional components of this matrix include glycosaminoglycans (GAGs) and proteoglycans which play a role in resisting compressive forces in tissues. The architecture of this matrix can shift over time in response to a constant pressure that stimulates matrix breakdown, matrix resynthesis and remodeling of the tissue. To accelerate tooth movement, agents increase the rate of matrix degradation during the period in which force is applied to the tooth.
  • FIG. 2A shows an exemplary removable appliance 15 adapted to fit over teeth on a jaw 16. The appliance can be coated with a drug, chemical agent, or a bioactive agent. In one embodiment, the drug is inactive until contact with water or saliva. Alternatively, release of the agent can be stimulated by water or by saliva. Thus, in one case, upon wearing, saliva activates the drug/agent and allows the drug/agent to seep out and treat the patient through the oral cavity of the patient. The substance can also be delivered through the patient's gingiva.
  • The appliance can release the agent to the oral environment when the appliance is placed over the teeth. Such means may comprise a layer which includes the agent. The layer may be formed over at least a portion of the surfaces of the repositioning appliance. These surfaces include both the cavity surfaces, the surfaces within the cavities which contact the teeth when in place, and the external surfaces, the surfaces of the appliance which contact the cheeks and lips when in place. The layer may be comprised of various materials and may take a variety of forms. For example, the layer may consist essentially of the agent. In other words, the agent may be attached directly to a surface of the polymer shell of an elastic repositioning appliance. This may be achieved by applying the agent (optionally in an inert carrier or diluent) itself to the surface utilizing a number of methods, such as spraying, painting and/or dipping. When the repositioning appliance is placed over the patient's teeth, the agent may then be released to the oral environment.
  • Alternatively, the layer may comprise the agent present in or on a carrier or binder which promotes adhesion or attachment to the appliance and/or which creates a matrix from which the agent can be released by diffusion or dissolution. In one embodiment, the agent is dissolved in the carrier or binder. In this case, the agent may be provided in powder or similar form and dissolved in a liquid solvent. The result may be a solution which may be applied to a surface of the shell, typically by spraying, painting and/or dipping, to form a coating or film. When the repositioning appliance is placed over the patient's teeth, the agent may then be released from the coating to the oral environment. Release may be due to activation or deactivation of the carrier or any other releasing mechanism, such as by enzymes or proteins in saliva. Or release may be due to degradation of the carrier by contact with, for example, saliva. In some cases, the binder or carrier may evaporate upon application to the layer to the surface leaving the agent behind. In these cases, the agent may be released in a similar fashion as when the agent is directly attached to the surface, as described above. It may be appreciated that any agent, particularly fluoride materials, antibiotics, bleaching materials and breath fresheners, may be delivered to the oral environment in this manner.
  • In another embodiment, the agent is encapsulated or suspended in the layer. A common material for suspension of an agent is a semisolid material, such as a gel, jelly or putty. Such a material may be applied to a surface of the shell by spraying, painting and/or dipping to form a coating or film. Here, as in all cases, suspension is not limited to a scientific definition and may refer to any situation in which a carrier holds, contains, supports or otherwise includes an agent. Alternatively or in addition, the semisolid material may be deposited in the cavities of the polymer shell which are shaped to receive the teeth. The cavities may be filled to any desired level. When the repositioning appliance is positioned over the teeth, the teeth will directly contact the semisolid material in the cavities and displace any extra material as the teeth are inserted into the cavities. Therefore, it is desired to fill the cavities to a level which will avoid excess overflow of the material from the appliance. Delivery of an agent by use of a semisolid suspension material is common in bleaching treatments and fluoride treatments, for example. However, such treatments apply the material with the use of a tray or generic appliance which does not apply repositioning forces to the teeth. By modifying a repositioning appliance, as described above, orthodontic treatment may continue throughout the delivery of such agents. It may be appreciated that any agent, particularly fluoride materials, antibiotics, bleaching materials and breath fresheners, may be delivered to the oral environment in this manner.
  • Another common material for encapsulation or suspension of an agent is a controlled-release material. Thus, the layer may be comprised of a rate-controlling material wherein the rate controlling material controls the rate at which the agent is released from the layer. Controlled-release or rate-controlled materials deliver a predetermined amount of an agent at a predetermined rate. Often such delivery maintains a steady-state concentration of an agent in an environment within a desired therapeutic range for a prolonged period of time. Thus, a prescribed dosage may be delivered. In addition, the ability to sustain delivery eliminates the need for repeated applications of the agent for dosed delivery to the oral environment.
  • Although such controlled release materials may be provided as a semisolid material, such as a gel, jelly or putty, as described above, these materials may also be provided as a solid material which is attached to the polymeric shell of the repositioning appliance. One type of controlled-release material comprises a polymer matrix membrane within which finely dispersed particles of an agent are suspended. The agent may diffuse through the matrix membrane according to a concentration gradient. Alternatively or in addition, the agent may be released by degradation of the polymer matrix membrane material. In either case, the controlled-release material may be provided as a sheet which may be laminated to a surface of the shell. The controlled-release sheet may be layered with the elastomeric polymer and vacuum formed over a mold to form the repositioning appliance. The controlled-release material may be arranged so that it is present on the inside or outside surfaces of the appliance depending on the material and desired application. Or, the controlled-release sheet may be laminated or bonded to a surface of the polymeric shell after forming to supply agent delivery in desired areas. Alternatively, the controlled-release material may be provided as a tablet or similar mass which may be inserted into the polymeric shell of the repositioning appliance. The agent may then elute from the tablet into the oral environment over time.
  • In another embodiment, the agent may be held within pores of a material and may elute out at a controlled rate from the pores. The agent itself may be absorbed into the pores of the material, or the agent may be suspended in a carrier which is absorbed into the pores of the material. In the latter case, the agent may be released from the carrier by diffusion and/or by controlled degradation of the carrier material. This may incorporate a rate-controlling mechanism in addition to the controlled-release of the agent from the pores. As mentioned, in some cases, enzymes in the patient's saliva will activate the release or degrade the carrier material to release the agent. It may be appreciated that the agent may be released by a combination of any of the release methods.
  • In a further embodiment, the polymeric shell of the repositioning appliance itself comprises a controlled-release material containing the agent. In this case, at least a portion of a polymeric shell is formed from a controlled release material wherein the rate controlling material controls the rate at which the agent is released from the shell. As previously described, the controlled-release material may be a provided in the form of a sheet. Thus, the sheet of controlled-release material may be vacuum formed over a mold of the patient's teeth to form a repositioning appliance itself. In this manner, no additional elastomeric materials may be needed to form the appliance. The controlled-release material may be a polymer matrix membrane, a porous material or any suitable material. Controlled-release may be designed so that the elution rate of the agent corresponds to the repositioning rate of the teeth. The agent may elute throughout the repositioning process, concluding as the teeth reach the desired arrangement prescribed by the appliance.
  • In another embodiment, the appliance is made from a polymeric material that exhibits reduced stress relaxation and creep when used as a tooth positioner in the oral cavity. Tooth positioners are made from polymeric materials. Once fabricated the tooth positioners are coated with a thin layer of a polymeric material. This coating serves to protect the tooth positioner from the potentially harmful environmental effects of salivary components, water and temperature. The physical properties of the polymeric coating (e.g, durometer, lubricity, elasticity, etc.) may be adjusted by modifying the polymer chemistry. Furthermore, a wide variety of substances may be combined with the polymeric coating solution to provide ancillary patient benefits. For example, flavorants may be combined with the polymeric coating and released over time to help control oral malodor. Drugs to control gingivitis or treat periodontal disease may also be combined with the polymeric coating. Finally, biocompatible dyes or colorants contained in the polymer matrix may be released when exposed to salivary fluids. The gradual disappearance of the colorant may signify whether or not the tooth positioner is being worn by the patient. The polymeric coatings applied to the dental appliance serve as a protective barrier to the harmful effects of salivary components, temperature and water and can contain flavorants, dyes, polymers, surface active molecules, antimicrobial agents and drugs.
  • In a still further embodiment, the releasing means coupled to at least some of the repositioning appliances comprises a reservoir formed in the shell of the appliance in addition to the cavity which receives the teeth. Typically, a rate controlling membrane is disposed over the reservoir wherein the rate controlling membrane controls the rate at which the substance is released from the reservoir. The reservoir may be pre-filled or pre-loaded with an agent or substance for delivery. In this case, the appliance may be ready for insertion or use upon removal from any packaging without the need of loading the appliance with the agent for delivery. If the releasing means is designed for a single delivery period, the appliance may be worn throughout the prescribed repositioning period and then disposed of. If the releasing means is designed for multiple delivery periods, the reservoir may be replenished with the agent to be released any number of times throughout the prescribed repositioning period. It may be appreciated that any agent, particularly fluoride materials, antibiotics, bleaching materials and breath fresheners, may be delivered to the oral environment in this manner.
  • In some instances, it may be desirable to change a visual characteristic of the polymeric shell of an oral appliance. Such appliances comprise a polymeric shell having a cavity shaped to be removably placeable over the teeth and a material on or within the shell that changes a visual characteristic of the shell. Such a change is typically in response to a change in the environment. In some cases, the visual characteristic is a color, such as green, red or blue. Thus, the appliance may appear colored or a particular color under certain environmental conditions, either in the oral environment or when removed. The described material may be a dye which changes color in response to a change in temperature. For example, the dye may change color when the appliance is removed from the mouth and changes temperature from body temperature (37° C.) to room temperature (25° C.). Similarly, the dye may change color when the appliance is rinsed with cool water.
  • The appliance can be used to provide an intra-oral drug delivery system. In addition to the drugs described above, other compounds can be used as well. For example, a drug coated appliance can be used to deliver desensitizing medication to sensitive teeth. The drug substance can simply be a small amount of the active ingredient in a desensitizing toothpaste or gel, such as Sensodyne®. The desensitizing agent is dispersed throughout the surface of the appliance and is delivered, at a substantially constant rate, to the patient's sensitive teeth for a relatively extended period of time.
  • Although the appliance may be pre-loaded with the agent and ready for use upon removal from any packaging, appliances that are not pre-filled or pre-loaded may require loading prior or immediately prior to placing the appliance over the teeth. Loading may comprise placing the agent in a teeth-receiving cavity. As described previously, the cavities may be filled to any desired level. When the appliance is positioned over the teeth, the teeth will directly contact the agent in the cavities as the teeth are inserted into the cavities. Alternatively, loading may comprise placing the agent into an agent release reservoir in the appliance immediately prior to placing the appliance over the teeth. The agent will then elute from the reservoir into the oral environment when the appliance is in place over the teeth. The elution rate may be controlled by a controlled release membrane which separates the reservoir from the surrounding environment. Loading may also comprise adhering a rate controlling material containing the agent to a surface of the appliance prior to placing the appliance over the teeth. Such a material may comprise a polymer matrix membrane which may be removably or permanently adhered to the polymeric shell of the appliance in desired areas for delivery of the agent. And finally, loading may comprise absorbing the agent into a porous material on or within the appliance immediately prior to placing the appliance over the teeth.
  • Repositioning of the teeth with the use of a position adjustment appliance involves placing the appliance over the teeth. However, the appliance is periodically removed for daily dental hygiene practices and other events throughout the repositioning protocol until the teeth are moved to at least near the desired tooth arrangement. While the appliance is removed from the teeth, the appliance may be replenished with the agent or substance for delivery. Replenishment may be performed immediately prior to each time the appliance is replaced over the teeth or it may be performed according to any prescribed protocol.
  • In another aspect, methods for introducing agent delivery to a prescribed tooth repositioning treatment plan are provided. A treatment plan is determined by an orthodontist or practitioner at the outset of orthodontic treatment. The plan involves moving the teeth through a series of intermediate configurations or arrangements to a final desired arrangement with the use of a system of tooth positioning appliances. Each appliance comprises a polymeric shell having cavities which is removably placeable over the teeth and wherein the cavities of successive shells are shaped to reposition teeth from one arrangement to a successive arrangement according to the treatment plan. The entire series of appliances may be provided at the outset of treatment, or a subset of appliances. In any case, the need or desire for delivery of an agent to the oral environment may occur at any point during the course of treatment. In such a case, an agent and/or means for releasing an agent to the oral environment may be coupled to an appliance at any time during treatment.
  • Means for releasing the agent may include a number of embodiments, including any such means previously described. Typically, means for releasing the agent comprises a layer including the agent, as previously described, and coupling comprises adhering the layer to at least a portion of a surface of the appliance. When the layer consists essentially of the agent, adhering may involve coating, spraying, dipping or painting the agent on the surface of the appliance. Thus, a pre-formed appliance may simply be coated with the agent prior to insertion in the patient's mouth. When the layer comprises an agent present in or on a carrier or binder, adhering may involve attaching the carrier or binder a surface of the appliance. Similarly, when the agent is encapsulated in the layer, the layer may be attached to the surface of the appliance. The layer may comprise a sheet of rate controlling material wherein the rate controlling material controls the rate at which the agent is released from the layer. In this case, the sheet may be bonded to the surface of the appliance with an adhesive. Alternatively, the sheet may be attached to the surface by press fitting. The sheet and the surface may each be shaped so that they snap or fit together by pressing them together. For example, the sheet may have a formed protrusion and the surface a formed inset, wherein the protrusion fits into the inset when pressed upon the inset and holds the sheet in place. In many instances, the appliance may be porous or have a reservoir which can be loaded with a desired agent at any time the treating professional and/or the patient decide that it is appropriate. For example, an appliance can be immersed in a solution of the agent, allowing the appliance to absorb or adsorb the agent at a particular time.
  • In addition, the sheet may be pre-formed to a shape adapted for fitting against the surface of the appliance or a surface of the teeth or gingiva. For example, the sheet may be pre-formed to reflect the shape of the surface of one or more teeth or the gingiva, particularly along the gingival margin. The preformed sheet may then be held against that surface when the sheet is coupled to the appliance and the appliance is placed over the teeth. Coupling may involve any means of attaching the sheet to the appliance. In particular, the pre-formed sheet may further comprise an adhesive layer which may provide bonding of the sheet to the surface of the appliance.
  • The material to make the appliance of FIG. 2A can be supplemented with additional fillers such as electrically conducting fillers, magnetic fillers, illuminating fillers, piezoelectric fillers, and/or light sensitive fillers. The material properties of the appliance made with or without these additional fillers such as modulus, electrical resistance, material permeability, and birefringence (degree of orientation of the material or stress), illuminating patterns or patterns under special light sources may change after the appliance is worn over time, as these properties are altered due to changes in structure, organization, and/or spatial spacing between the fillers. For example, it is well established that electrical conductivity of filled composites scales with filler volume concentration according to percolation theory. Therefore, mechanical deformation or thermal expansion of the non-conductive polymer matrix will lead to increased average inter-filler spacing, or decreased filler volume concentration, and consequently decreased electrical conductivity. Examples of electrically conductive fillers include metals, graphite, electrically conductive polymers, semiconductors, and superconductors. These changes in properties can be used as an indicator for compliance and can be diagnosed by instrumentation. Similarly, separation of conductive fillers will also lower thermal conductivity, which can also be measured by instrumentations. If the fillers have magnetic behavior in the presence of external stimulation, such as diamagnetics (Cu, Au, Ag, etc.) and paramagnetics (e.g. Al, Cr, Na, Ti, Zr, etc.); or exhibit intrinsic magnetic properties, such as ferromagnetics (Fe, Co, Ni, etc.), antiferromagnetics (e.g. MnO), and ferromagnetics (MFe2O4), then separation of the filler spacing due to mechanical deformation of the polymer matrix can also lead to decreases in magnetic properties above the Curie temperature. Mechanical deformation of composites with illuminating fillers, such as those that exhibit luminescence, fluorescence, or phosphorescence, will result in decreased illumination intensity. Bending deformation or displacement of piezoelectric fibers can result in electrical potentials which can be either measured, or used to activate other electrically driven indicators (e.g. low power LED light). Fillers with optical properties which depend on external electric field, for example those that shift their absorption coefficients in the UV, IR, or visible spectrum can also serve as indicators of matrix deformation.
  • FIG. 2B shows a second embodiment of FIG. 2A. In this embodiment, an appliance 17 has a plurality of delivery nozzles 18A-18C that project from the appliance 17 to contact the patient's gum tissue on the side of the gum or in a periodontal pocket. The nozzles 18A-18C can be on either the frontal side, the lingual side, or both sides of the teeth on the jaw 16. Optionally, one or more reservoirs 19A-19C can store extra drug/agent for delivery through nozzles 18A-18C. In one embodiment, reservoirs 19A, 19B, and 19C can contain the same drug or substance. In another embodiment, reservoirs 19A, 19B, and 19C can each contain a different drug/substance. In yet another embodiment, reservoir 19A and 19C can contain the same drug and reservoir 19B can contain a different drug/substance. The combination of drug storage as discussed above is illustrative only and any suitable combination for storing a plurality of drugs or substances in a plurality of reservoirs 19A-19C can be used.
  • FIG. 2C shows a cross-sectional view of the appliance of FIG. 2B on an exemplary tooth. As can be seen, the nozzle 18A either stores the drug or agent or receives drug/agent from the reservoir 19A. Moreover, the nozzle 18A is adapted to be inserted into the gum of the patient to deliver the drug/agent to the patient. FIG. 2D is a cross sectional view of FIG. 2C without the tooth and gum line.
  • Referring now to FIG. 2E, another embodiment of a drug/agent delivery device is shown. In this embodiment, a plurality of drug/agent containers or modules 23 are positioned in an inside lining of a removable dental appliance 21. The appliance 21 is fitted over a tooth 25. During chewing or other oral activities, the appliance 21 carrying the modules 23 is pressed toward the tooth 25. At a predetermined pressure or force, one or more of the modules 23 burst, releasing the drug or agent into the oral cavity. In addition to being positioned inside the lining of the appliance 21, the modules 23 can also be positioned on an outside lining of the appliance 21 as well.
  • Turning now to FIG. 2F, yet another embodiment of a drug or agent delivery device is shown. In this embodiment, an attachment 27 is mounted on a tooth 25. The attachment contains a first material that is inactive absent the presence of a second material. The second material is coated on an appliance 29 and is also inactive in the absence of the first material. When the appliance 29 is worn over the tooth 25 and the attachment 27, the first and second materials react to form a drug or an agent suitable for intra-oral delivery.
  • Referring now to FIG. 3, another drug delivery system is shown. In this system, brackets and wires are used to effect tooth positioning as well as drug delivery. On the frontal side of the teeth, a base 20 and a plurality of brackets 24 are positioned on the teeth. Additionally, a wire 28 is positioned in the slots of the brackets 24. The base 20 and the brackets 24 contain drug/agent to treat the patient.
  • In an alternative embodiment, the fixed appliances can be mounted on the lingual side of the teeth as well. For example, a base 30 and a plurality of brackets 34 are placed on the rear or lingual side of the teeth, and a wire 38 links the base and brackets for orthodontic treatment and drug delivery.
  • In yet another alternative embodiment, the drug/agent can be delivered using bases and brackets and wires on both sides of the teeth such as that shown in FIG. 3.
  • Reservoirs can be positioned on the base and brackets to provide treatment drugs or agents. FIG. 4A shows a cross-sectional view while FIG. 4B shows a perspective view of a bracket with a reservoir. As shown in FIGS. 4A-4B, a bracket body 42 has a base region 46 and a slot 47 to receive a wire (not shown). Above the body 42 is a reservoir 44 that contains drugs or agents for delivery to the patient. The bracket body 42 and reservoir 44 can be of any suitable metal, or can be of a translucent or transparent plastic material or any suitable biocompatible metal. These general types of materials are commonly used in the practice of orthodontic care. It should be understood that the size and shape of the bracket body 42 and reservoir 44 are not critical and the exemplary bracket is described for purposes of illustration.
  • FIG. 4C shows another embodiment where the substance can be stored in a cap 48 that is received by the slot 47. The cap 48 can be used with a conventional bracket without the reservoir 44 as well as with the bracket of FIG. 4A. When used with the bracket of FIG. 4A, the substance in the cap can be the same as the substance in the reservoir 44 or can be different from the substance stored in the reservoir 44.
  • FIG. 4D shows yet another embodiment where the substance can be stored in a band 52 that encircles the slot 47. The band 52 can be used with a conventional bracket without the reservoir 44 as well as with the bracket of FIG. 4A. When used with the bracket of FIG. 4A, the substance in the band 52 can be the same as the substance in the reservoir 44 or can be different from the substance stored in the reservoir 44. Optionally, the band 52 can receive a substance from a band reservoir 54.
  • FIG. 4E shows yet another embodiment with a bracket 56 that has an opening 57 extending from one side of the bracket 56 to the other side of the bracket 56. A substance is provided in a housing 58 which can be ball-shaped or box-shaped, among others. A wire 59 is attached to the housing 58 and the wire 59 can be threaded through the opening 57. After reaching the other side of the bracket 56, the wire can be twisted or bent or otherwise secured to the bracket 56, as shown by a bent wire 59A. The bent wire secures the housing 58 to the bracket 56 for delivery of substances to the patient.
  • FIG. 5A shows another embodiment where a second reservoir is mounted on a second side of the teeth opposite to the side where the bracket of FIG. 4A is mounted. In this embodiment, a second reservoir 50 contains additional drugs or agents. The second reservoir 50 is connected to the reservoir 44 through a pipe 52 to replenish the drug or agent as needed.
  • In another embodiment, the reservoirs 44 or 50 can be recharged using a needle to inject additional drug/agent to the reservoirs. Alternatively, the reservoir 44 or 50 can be replaceable to replenish the drug/agent.
  • FIG. 5B shows another embodiment where a bracket 64 is used as a mount or support for a drug/agent housing 66 on a tooth 60. In this embodiment, the housing 66 abuts the gum or a surface of the oral cavity to expedite delivery of drug/agent to the patient's body.
  • FIG. 5C shows another embodiment where the bracket 64 is used as a mount or support for a drug/agent housing 68 on the tooth 60. In this embodiment, the housing 68 is spaced apart from the gum or a surface of the oral cavity to delivery drug/agent to the patient's body.
  • FIG. 5D shows yet another embodiment for delivery of drug or therapeutic agent. A permeable implant 70 is mounted on the patient's gum 71. A post or abutment 73 with a screw or threaded end 72 is mounted on the implant 70. A crown-shaped housing 74 contains a drug or agent that seeps or permeates through the abutment 73 and the implant 70 to be delivered to the patient's body.
  • FIG. 5E shows a screw embodiment where drug or agent is embedded in a screw having a head 76 and a threaded portion 75. The screw is tapped into the patient's gum where it delivers the drug or agent into the patient's body. In addition to screws, micro-staples can be used to deliver drugs to the body. Moreover, dentures and partial dentures can have drug(s) or agent(s) embedded therein to deliver drug to the patient's oral cavity or body. In addition, the drugs or agents can be embedded in spaces between teeth.
  • FIG. 6A shows another embodiment where energy is applied to an appliance 78 to affect teeth movement or drug delivery. In this embodiment, electricity is stored in an energy source 83 such as a battery. A switch 81 is used to deliver energy to the oral cavity. The switch 81 is controlled by electronics 79 such as a microcontroller. The electronics 79 delivers a predetermined amount of energy to treat the patient or to deliver drug.
  • FIG. 6B shows another embodiment where energy is applied to wires 80 and 82 to effect teeth movement or drug delivery. In this embodiment, electricity is stored in an energy source 88 such as a battery. A switch 84 is used to deliver energy to the oral cavity through wires 80 and 82. The switch 84 is controlled by electronics 86 such as a microcontroller. The electronics 86 delivers a predetermined amount of energy to treat the patient. The energy in one instance can be low-level electrical current to promote healing at the bone level. In another instance where the energy source 88 is connected through switch 84 to a material such as nichrome, the energy can be low level heat. In another instance where the energy source 88 is connected through switch 84 to a light emitting diode (LED), the energy can be light and when the LED is in a lasing mode, the energy can be a laser beam. The energy can be a magnetic field in another instance where the energy source 88 is connected through switch 84 to an inductor.
  • Ultra-sound can be used as well where the energy source 88 is connected through switch 84 to an ultrasound vibratory source or transducer. The transducers can be electronically activated to vibrate and emit ultrasonic pulses to promote bone healing. In addition to healing the bone, some of the pulses penetrate the tooth and are returned to other transducers on a sensor array. These echo or reflected pulse signals, after being detected by transducers on the array, can be collected, analyzed and compared to produce a recreation of the tooth or dental structure being examined. By collecting reflected or scattered signals from as many angles as possible, the electronics will have sufficient time-of-flight measurements to perform a tomographic computation to model or map the tooth volume.
  • Vibrations can be used to inflame or irritate the bone structures to promote tooth movement as well. In one embodiment, the appliance is coated with a material that can expand and contract upon receipt of an electrical stimulus. Electroactive polymer composites, fabricated from an organic filler possessing very high dielectric constant dispersed in an electrostrictive polymer matrix, can be used as dental actuators. The composite can have a matrix made from electrostrictive poly(vinylidene fluoride-trifluoroethylene), an electroactive copolymer and a filler such as an organic semiconductor, copper-phthalocyanine. The composite acts as artificial muscles. Upon actuation, they can repetitively contract and expand to create vibrations on the teeth to encourage teeth movement.
  • Alternatively, memory-materials such as nitinol can be used and the contraction/expansion can be controlled. Heat, electrical, or microwave energy can be used on other materials to induce them to change state and to inflame or stress the bone/gum structure to induce teeth movement.
  • In another embodiment, a wire can be attached directly to the teeth or indirectly to the teeth using a removable appliance and the wire can be repetitively wound and unwound using a micro-motor. Such repetitive movements apply stress that inflame or irritate the gum or bone structure to enhance teeth movement.
  • Thus, as discussed above, FIGS. 6A-6B show that the substance (in this case battery 83 or 88) provides energy to the oral cavity. The energy can be physical, electric, light, heat, sound, magnetic or electromagnetic energy.
  • In addition to injecting energy, the devices of FIGS. 6A-6B can be used to irritate or inflame the oral structure. For instance, the devices can be used to inflame gingival or the bone structure of the teeth to encourage teeth repositioning.
  • In another embodiment, the appliances can be used to enhance drug delivery by using electrical current to induce drug movement. For example, the drug molecules can be transported between one electrical pole to another electrical pole. Another implementation provides a positive current on one side of the appliance, and a negative current on the other side of the appliance to force the drug through the gum or dental tissue.
  • In another embodiment, the appliance induces a change in the polarity of the teeth. The tooth is normally negatively charged and the drug in the appliance is positively charged. Opposite charges attract and bond to each other and the drug or agent can be attached to the tooth surface by “ionic bonding”.
  • In yet another embodiment, the appliance containing drug can be configured so that positively charged ions are transferred to the teeth. The tooth polarity changes from negative to positive. The positively charged tooth ions repel the positively charged ions from other substances. For example, plaque ions are repelled from tooth ions such that plaque can be removed from the oral cavity.
  • In yet another embodiment, the appliance applies submucosal iontophoresis to accelerate tooth movement. lontophoresis stimulates osteoclasts in the periodontal pression side and osteoblasts in the tension side.
  • Agents to Accelerate or Decelerate Movement
  • In one embodiment, the substance accelerates tooth movement by degrading the matrix. Matrix degradation can be stimulated either directly or indirectly. Chemical agents may act as enzymes to directly breakdown structural proteins in the matrix. Proteases degrade protein, elastases degrade elastin, collagenase degrades collagen, among others. Other drugs or hormones such as relaxin, estrogen, or nicotine may act on cells within the matrix and cause those cells to secrete endogenous matrix degrading enzymes. Many of these naturally occurring enzymes are known as matrix metalloproteases (MMPs) and in the periodontal space these enzymes include MMP-1, MMP-2, MMP-3, MMP-8, and MMP-9. The expression and function of these enzymes is usually under tight control, in part, by a concomitant expression of a group of molecules known as tissue inhibitors of matrix metalloproteases (TIMPs).
  • A large number of drugs have been developed to prevent matrix breakdown. These drugs are typically useful as anti-inflammatory agents or anti-cancer therapies. Some of these candidates have been used to prevent or treat periodontitis. A very few drugs are available to stimulate matrix breakdown and those are commonly used for indications like wound debridement, breakdown of blood clots, or stimulating gastrointestinal digestion. Their utility in the setting of orthodontic remodeling would need to be tested in appropriate preclinical models.
  • One exemplary drug can be Granulex or Xenaderm.™ whose active ingredient is trypsin. This drug is indicated for wound debridement, wound healing, or varicose vein treatment. This ingredient breaks down many different types of protein. Alternatively, another active ingredient such as hyaluronidase can be used to degrade hyaluronan which is thought to have a role in resisting compressive forces in tissue. Also, elastase can be used to degrade elastin preferentially and may help to both accelerate remodeling and prevent relapse.
  • Another exemplary drug can be Alteplase or Activase® whose active ingredient is tissue plasminogen activator. These drugs are indicated for thrombolytic therapy. In the presence of a thrombus Activase binds to fibrin and converts plasminogen to plasmin to stimulate fibrinolysis. These drugs may only work in the context of blood clots.
  • Examples of other exemplary drugs are Arco-Lase®, Creon®, Kutrase®, Kuzyme®, Ultrase®, and Viocase®, whose activity depends on a combination of enzymes: amylolytic, proteolytic, celluloytic and lipase. These drugs are indicated for the treatment of gastrointestinal disorders due to poor digestion. The drug, Arco-Lase, comes in soft, mint flavored tablets. All these drugs warn that they may irritate oral mucosa, which may be an indication that they could work to soften gum tissue as well as degrade food proteins.
  • Examples of other exemplary drugs are Accuzyme®, Gladase®, and Panafil® whose active ingredient is papain. This drug is indicated for treatment of wound debridement. Papain combined with urea dissolves non-viable protein but supposedly leaves viable tissue intact.
  • Another exemplary drug can be Potaba® whose active ingredient is aminobenzoate potassium. This drug is indicated for antifibrosis therapy for scleroderma, Peyronie's disease, dermatomyositis and morphea. This ingredient is part of the vitamin B complex and is reported to soften tissue with long term use.
  • Another exemplary drug can be Aldurazyme® or Laronidase, whose active ingredient is alpha-L-iduronidase. This drug is indicated for treatment of mucopolysaccharidosis. This ingredient is a lysosomal hydrolase that breaks down the glycosaminoglycans: dermatin sulfate and heparan sulfate.
  • Another class of enzymes that may help to loosen gum tissue for the purpose of accelerating tooth movement is the elastase family of enzymes that break down elastin. Addition of these enzymes or induction of endogenous elastase activity could also serve to prevent tooth relapse following successful orthodontic tooth movement. Elastase enzymes are produced by a number of inflammatory cells for example neutrophil elastase, leukocyte elastase, granulocyte elastase or macrophage elastase (which is also called MMP-12). As described below, agents or activities that stimulate inflammation, cause an increase in the local concentration of these inflammatory cells and therefore an increase in the local concentration of elastase enzymes.
  • Additional enzymes that would also augment tissue degradation include hyaluronidase and cathepsin. Hyaluronidase is an enzyme found in mucous membranes that specifically degrades hyaluronic acid which is part of the glycosaminoglycan matrix molecules important for resisting compressive force. The cathepsin family of lysosomal enzymes is a large and varied family of cystein proteases important in many disease processes that involve tissue disruption. Cathepsin B, for example, is known to play a role in demyelination, emphysema, rheumatoid arthritis and neoplastic infiltration. Cathepsin B is also known to be elevated in gingival crevicular fluid during orthodontic tooth movement and is thought to be involved in extracellular matrix degradation in response to mechanical stress. Another cathepsin, cathepsin K, is upregulated in odontoclasts and osteoclasts during tooth movement and may play a role in root resorption during this process.
  • In general, the addition of any enzyme that is capable of breaking down a component of the gingival extracellular matrix is capable of accelerating tooth movement. An alternative means to disrupt the tissue matrix is by addition of compounds that can interfere with the normal interaction between different components of the matrix architecture. For example, a family of proteins known as integrins serve to link cells to the extracellular matrix. Addition of a class of agents known as disintegrins can block this interaction and loosen the connective structure of the matrix. Disintegrins are found in snake venoms and are useful to this species because of their ability to facilitate tissue penetration of the venom. Disintegrins found in many snake species are called variously albolabrin, applagin, batroxostatin, bitistatin, echistatin, elegantin, flavoridin, halysin, kistrin, triflavin, and trigramin.
  • Primary constituents of the extracellular matrix are collagen, elastin, fibronectin, laminin, integrins, proteoglycans and glycosaminoglycans. Additional constituents are fibrillin, versican, link protein, entactin, tenascin, vitronectin, decorin, cadherin and many others. Many of these components bind to one another to add rigidity and structural integrity to the tissue matrix architecture. Often these interactions are through specific binding sites involving an RGD (arginine-glycine-aspartate) peptide sequence. Antibodies or other binding agents that target these binding sites are capable of disrupting matrix integrity and loosening the tissue. Specific antibodies have been developed to all of these matrix proteins, though only the subset of enzymes that target epitopes important in protein-protein interactions are likely to cause tissue matrix disruption. Antibodies or other binding agents will be effective if they have an affinity for the binding sites that is greater than that of the native proteins. One means of generating a large number of agents capable of binding at, for example, an RGD site is by screening with phage display peptide libraries such as described in Odermatt et al.
  • Tissue extracellular matrix degradation may be brought about by direct application of enzymes and binding agents as described above, or through indirect means by addition of agents that stimulate the overexpression of endogenous enzymes. An example of this type of agent includes drugs that alter the expression or activity of matrix metalloproteases (MMPs). MMPs are a family of structurally related, protein-degrading enzymes that require calcium ions for structural conformation and zinc ions in their active site for function. The MMP enzymes can be administered either alone or in combination to directly impact tissue degradation. As mentioned previously, MMP-1, MMP-2, MMP-3, MMP-8 and MMP-9 are the matrix degrading enzymes known to be active in the periodontal space. Matrix metalloproteases are also known as matrix metalloproteinases, collagenases, gelatinases, or CLGs. For example, depending on the nomenclature used, MMP-2 is also called collagenase type 4 (A), gelatinase A, or CLG 4 (A). Some MMPs are known by additional names due to the fact that their discovery preceded knowledge of the family characteristics. For example, MMP-3 is also known as stromelysin-1 or transin. The MMP enzymes listed above have been purified and are available commercially.
  • Collectively, the MMP family of enzymes is capable of digesting almost all of the components of the extracellular matrix. They often work best in concert whereby an MMP isotype with selective collagenase activity will cleave the type I collagen triple helix allowing access to additional MMP enzymes which then further degrade the protein. MMP-3, in contrast to MMP-1 and MMP-2 does not break down type I collagen but can degrade proteoglycan and fibronectin which are other important constituents of the extracellular matrix. As they occur naturally in periodontal tissue MMP activity is finely balanced by the presence of endogenous enzyme inhibitors known as tissue inhibitors of metalloproteases (TIMPs). Adding exogenous MMPs to the tissue can alter the balance of activity to bring about relatively more matrix degradation and tissue disruption that may aid in tooth movement.
  • An exemplary drug that may work to accelerate tooth movement by stimulation of endogenous MMP activity is Prepidil® (dinoprostone) whose active ingredient is prostaglandin E2. This drug is indicated for treatment of induction of labor. Prostaglandin E2 has been shown to enhance MMP-1 (collagenase) and sometimes MMP-3 (stromelysin) expression in human gingival tissue. Another exemplary drug that contains the same active ingredient is Prostin E2® which is indicated for termination of pregnancy.
  • Another exemplary drug can be Fluprostenol. This drug is a potent luteolytic agent with prostaglandin F2alpha activity. Research shows that it can increase MMP-1 production and degrade connective tissue in human gingiva.
  • Another exemplary drug can be Nicoderm®, Commit® and Nicorette®, whose active ingredient is nicotine. This drug is indicated for treatment of smoking cessation. This ingredient has many effects such as vasodilation, but research shows it can increase collagenase activity and matrix turnover in gingival tissue.
  • Another example of an agent that stimulates the overexpression of endogenous enzymes is keratinocyte-derived collagenase stimulatory factor also known as stratifin. Delivery of this agent can cause upregulation of collagenase enzymes in fibroblasts present in gingival tissue. An even more direct way to stimulate overexpression of matrix degrading enzymes is to use gene therapy techniques to either transfect local cells with constructs encoding these enzymes or with enhancer or promoter elements capable of stimulating endogenous gene transcription of those particular enzymes. For example, overexpression of manganese superoxide dismutase is known to cause activation of MMP-2. Agents that elevate the intracellular concentration of cyclic adenosine monophosphate (cAMP) are also capable of promoting MMP-2 overexpression, increasing the activity of this enzyme and decreasing collagen content in tissue. Examples of agents with this capability are isoproterenol, prostaglandin E2 and forskolin. Relaxin is another agent that is capable of enhancing MMP-2 production.
  • In general any agent that triggers an inflammatory response can bring about stimulation of MMP overexpression and matrix degradation. Another large family of molecules of interest in this regard is the cytokine family of molecules. Cytokines are agents usually secreted by cells to bring about a response in another cell. Thus, they are important in cell to cell communication. A number of common inflammatory cytokines have been elucidated and many more are likely to be discovered and characterized in the future. Inflammatory cytokines are released after injury and help to recruit additional inflammatory cells into the area of tissue damage. Orthodontic tooth movement usually involves a mild inflammatory response. If exacerbated, this inflammatory response will likely promote additional tissue degradation and may speed the process of tooth movement. The most commonly known inflammatory cytokines are interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNFα) and transforming growth factor-beta (TGF-β).
  • There are many ways to stimulate an inflammatory response beyond direct addition of inflammatory cytokines. Inflammation can be brought about by virtually any means of causing local tissue damage. Mechanical force such as pushing, pulling or stretching the tissue can trigger release of local pro-inflammatory cytokines. Tearing or abrasion of either soft tissue or bone can similarly trigger an inflammatory reaction. Addition of an irritant such as a powder, polymer, or any type of foreign body can incite inflammation. Alteration of local pH into either an acidic or basic range beyond normal physiological pH can cause inflammation. Elevated temperature can have a similar effect as can the addition of other energy sources such as ultrasound, or electrical energy.
  • Regardless of what means is used to stimulate the activation of local tissue degrading enzymes there is a need for limiting this activation so as not to cause significant and irreversible tissue damage. What is sought is a mild enhancement of the inflammatory response normally associated with orthodontic tooth movement. The ability and mechanisms by which these limitations can be established will depend on the stimuli used to enhance inflammation. If agents or enzymes are administered directly, their activity can be controlled by monitoring the dose-response relationship and choosing the most appropriate concentration. If indirect stimulators of endogenous enzymes are used then the tissue itself may provide some regulatory feedback (e.g. upregulation of TIMPs) to modulate and limit the overall response. The ultimate goal in this case is to strike the right balance to bring about moderate tissue disruption.
  • In one implementation, the drug or bioactive agent assists in a “retention” phase, without which there is a tendency for the teeth to return to their initial position (relapse). The underlying cause for this relapse appears to reside in the gingival tissue which, unlike bone and the PDL, is not resorbed during orthodontic treatment but is compressed and consequently retracts. On the pressure aspect of the gingiva there is an increase in the number and size of elastic fibers and an increase in collagen. The elastic forces stored in the compressed gingiva can exert pressure on the tooth and cause relapse after the release of retention. Procedures such as gingival circumferential fiberotomy have been introduced to disconnect the compressed gingiva from the tooth and have demonstrated some success in preventing tooth relapse.
  • Bioactive agents can accelerate tooth movement. The bioactive agents described above work primarily by enhancing collagen or elastin degradation. If delivered to the appropriate local tissue bed these agents should, then, limit the increase in collagen and elastin accumulation on the pressure side of the gingiva and reduce the tendency to relapse. There are, however, other mechanisms to prevent tooth relapse. One way to chemically stabilize tooth position after completion of the orthodontic movement involves increasing the number of chemical crosslinks between collagen fibers, particularly on the tension aspect of the tooth. Increased crosslinking provides more structural stability to the new fiber orientation in the gingival tissue. Formaldehyde and glutaraldehyde are the most well known agents capable of crosslinking collagen and these agents are commonly used to treat bioprosthetic tissue prior to use of that tissue as a medical implant. Standard formulations of formaldehyde and glutaraldehyde are likely too toxic to be used in situ, but may be modified to reduce their tissue toxicity.
  • Chemical crosslinking agents can be used to crosslink extracellular matrix components for many different indications. For example, Genipin is a relatively non-toxic, naturally occurring crosslinking agent that can be used. Carbodiimide is considered to be a somewhat less toxic crosslinking agent, though at least one study showed that genipin was better able to stimulate intermolecular collagen crosslinks compared to carbodiimide. Intermolecular rather than intrahelical crosslinks are more likely to bring about the desired tissue stabilization. 1,6-diaminohexane (DAH) is also an effective collagen crosslinking agent that has been shown to be slightly less toxic than cardodiimide especially in the presence of glycosaminoglycans (which are naturally occurring in gingival tissue). Dimethyl 3,3′-dithiobispropionimidate is yet another example of a crosslinking agent reported to be more biocompatible than standard agents like glutaraldehyde
  • Another class of compounds that may be useful is the reducing sugars including glucose, ribose and derivatives of these sugars. The slow crosslinking reaction between reducing sugars and biological amines leads to the development of advanced glycation endproducts (AGEs). AGEs accumulate over the course of a person's lifespan and a number of detrimental conditions have been attributed to this accumulation including increased vascular and myocardial stiffness, endothelial dysfunction, altered vascular injury responses and atherosclerotic plaque formation. In the setting of orthodontic applications, however, increased crosslinking for a limited period of time could prove beneficial and these agents are relatively simple sugars not associated with any additional toxicity. Acceleration of AGE-related crosslinking can be brought about by increasing the concentration of reducing sugars and also by application of external energy such as UV irradiation.
  • The bioflavonoids is another broad class of compounds that could prove very useful in this endeavor. They are exemplified by molecules such as riboflavin, catechin and rutosides. Many of these compounds are found naturally in food substances like red wine and green tea. They tend to be very biocompatible but are also known to promote the crosslinking of collagen either alone or in combination with adjunctive energy like UV-A or rose Bengal/white-light irradiation. In the case of riboflavin-UVA, this treatment has been used clinically to promote collagen crosslinking of the sclera to increase its biomechanical strength for the treatment of progressive myopia.
  • Although it appears that the accumulation of extracellular matrix proteins in gingival tissue has an important role in tooth relapse, there is also evidence that bone remodeling plays a part. Experimental data from the School of Dentistry in Tohoku University, Japan, showed the ability of a bisphosphonate (risedronate) to prevent tooth relapse. Risedronate is a potent blocker of bone resorption. When applied topically during the phase of orthodontic tooth movement, it reduced tooth movement. When applied during the retention phase, it was able to inhibit relapse.
  • In another embodiment, the substance can be anesthetics and analgesics such as benzocaine, lidocaine and prilocaine, among others, that are locally released through the appliance. These substances may promote patient compliance for appliance usage/wear, and also for the palliative relief of oral discomfort due to intraoral ulcers, cancer sores, and other lesions associated with trauma, disease, or surgical procedures.
  • In yet another embodiment, the drug can be nicotine to relieve patient discomfort or to treat another disease. As discussed in U.S. Pat. No. 4,215,706, the content of which is incorporated by reference, tobacco (donor tobacco) is contacted with a receiving substrate on the appliance which has been treated with a strong acid or an ammonium salt of a strong acid. Part of the nicotine in the donor tobacco is transferred from the donor tobacco to the receiving substrate. Thereafter the donor tobacco and the substrate may be separated. The donor tobacco has a reduced nicotine content for pain relief or medical treatment.
  • In yet another embodiment, the appliance can be used to provide a local release of breath fresheners such as menthol, peppermints, spearmints, wintergreen, zinc gluconate, citrus, clove and thymol, among others, that may promote patient compliance to facilitate treatment. More breath freshener information is shown in US Patent Publication No. 20040115137, the content of which is incorporated by reference.
  • Additionally, the substance can prevent tooth decay through fluoride treatment. Treatments include toothpastes, gels, rinses and varnishes. Gum disease, such as gingivitis or periodontitis, is caused by bacterial growth associated with dental plaque and calculus deposits. The most common recommendation for preventing such bacterial growth is to mechanically remove the plaque from the tooth surfaces. However, chronic gingivitis and tooth decay have plagued many individuals who in fact comply with good oral hygiene methods and plaque removal. This may be due to a variety of factors including genetic predispositions, illnesses, mouth breathing, and medical treatment programs. In such cases, bacterial control may be accomplished with the use of antibacterial drugs. A common antibacterial agent shown to be effective in reducing the activity of many common strains of oral flora is chlorhexidine. Chlorhexidine is a cationic biguanide microbicide with a broad spectrum of activity against many forms of bacteria and fungi. Therefore, it has been a popular agent in many studies of gingivitis reversal. Chlorhexidine has traditionally been delivered to the oral environment through the use of rinses, such as Peridex® (Proctor and Gamble). Sustained delivery to the gingiva has also been attempted with the use of chlorhexidine impregnated dental floss and dental appliances, such as trays or mouthguards. Another frequently prescribed antibacterial agent is tetracycline. Tetracycline is a broad spectrum antibiotic which is effective against virtually all common groups of pathogenic bacteria, both gram positive and negative. Tetracycline may be combined with an antifungal agent, such as amphotericin, to provide activity against fungi. Tetracycline has traditionally been delivered to the oral environment through systemic administration, although localized delivery has been attempted with the insertion of tetracycline-filled hollow fiber devices into periodontal pockets and the use of tetracycline laden dental appliances, such as trays and mouthguards. In addition, a number of other antibacterial drugs are available for dental and periodontal therapy.
  • Cosmetic treatments often include tooth bleaching or whitening and breath freshening products. Discolorations of enamel and dentin may occur due to aging, consumption of staining substances (coffee, tea, colas, tobacco), trauma, staining due to systemic tetracycline (antibiotic) therapy, excessive fluoride, nerve degeneration and old dental restorations. Bleaching lightens these discolorations for a whiter or brighter appearance. Typically, a bleaching gel is placed in a thin custom-fitted tray that fits over the teeth. The tray is worn at night for usually 10 to 14 days and may require periodic re-bleaching treatments for approximately one or two nights every six months. Breath freshening products are often used by patients to treat halitosis or for enjoyment of the taste. These include a variety of sprays, rinses, mints, gums, or candies, to name a few.
  • Additionally, the substance can include chemicals that irritate the gum or bone. Alternatively, the substance can inflame a bone.
  • Often the use of a combination of drugs or bioactive agents can impart more benefit than the use of any single agent. The appliance used to deliver therapeutic or cosmetic agents to oral tissue can be easily adapted to deliver more than one agent and can also be adapted to deliver specific agents to select locations within the oral tissue. For example, a drug that accelerates collagen and/or elastin degradation might be delivered to the pressure aspect of the gingiva where there is typically an increase in the number and size of collagen and elastic fibers that oppose tooth movement. Simultaneously, the appliance might deliver an agent that promotes the crosslinking of collagen to the tension aspect of the gingiva to help stabilize the tooth movement achieved with the appliance. In one embodiment, reservoirs 19A, 19B, and 19C (FIG. 2B) can contain the same drug or substance. In another embodiment, reservoirs 19A, 19B, and 19C can each contain a different drug/substance. In yet another embodiment, reservoir 19A and 19C can contain the same drug and reservoir 19B can contain a different drug Thus, in one example bleaching agents can be stored in one reservoir and delivered to the tooth itself while a second reservoir can store and deliver an agent capable of accelerating tooth movement to the gingiva surrounding the tooth.
  • Just as different agents need not be delivered to identical locations within the oral tissue, different agents need not be delivered at the same time. It may be advantageous to deliver one agent at the beginning of orthodontic treatment and a different agent at another point during the treatment. An example of this treatment regimen would be delivery of agents to accelerate tooth movement during the first weeks of orthodontia and delivery of agents to prevent tooth relapse following the period of tooth movement.
  • In some cases it is necessary to add one agent to modify the activity of another agent. For example, a buffering agent may be needed to alter the pH of a drug so as to make the therapeutic agent less caustic. In another case it might be necessary to add one agent to stabilize or activate the therapeutic agent once it has been released from the appliance. An alternative exemplary case would be the use of more than one agent that have the same general effect as, for example, two agents that are likely to accelerate tooth movement. Two or more agents may be employed rather than one either because they will act synergistically by employing different modes of action to bring about an effect or because they have different unwanted side effects that can be reduced by lowing the dose delivered of each but maintaining a beneficial therapeutic effect because of the ability of the agents to work together in concert.
  • The terms and expressions which have been employed in the foregoing specification are used therein as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding equivalents of the features shown and described or portions thereof, it being recognized that the scope of the invention is defined and limited only by the claims which follow. For example, although films or appliances have been disclosed as mechanisms for delivery drugs or substances, droplets can be used to deliver substances to the patient as well. Typically, droplets can be sized within the range of about 1 to 200 microns and may be presented to the mucosa within a liquid, solid, or gaseous suspension, including an aerosol system which refers to a gaseous suspension of particles dispensed within the form of a mist. Other embodiments for delivering drugs or substances can be used as well. Whereas particular embodiments of the present invention have been described herein for purposes of illustration, it will be evident to those skilled in the art that numerous variations of the details may be made without departing from the invention as defined in the appended claims.

Claims (40)

1. A method for delivering one or more substances, comprising:
attaching the one or more substances to an oral structure; and
fluidly providing the one or more substances from the oral structure into a body at a pre-selected dose.
2. The method of claim 1, wherein one or more of the substances is a therapeutically effective amount of a drug or a bioactive agent.
3. The method of claim 1, wherein one or more of the substances accelerates or decelerates tooth movement.
4. The method of claim 1, wherein one or more of the substances induces irritation of the oral structure.
5. The method of claim 1, wherein one or more of the substances induces inflammation of a bone structure or surrounding tissue.
6. The method of claim 1, wherein one or more of the substances is delivered through gingiva.
7. The method of claim 1, wherein one or more of the substances is positioned on a bracket, a dental attachment, a bracket auxiliary, a ligature tie, a pin, a bracket slot cap, a wire, a screw, a micro-staple, a denture, a partial denture, a dental implant, a periodontal probe, a periodontal chip, a film, or a space between teeth.
8. The method of claim 1, wherein one or more of the substances is positioned on a removable appliance.
9. The method of claim 8, wherein one or more of the substances is positioned on the removable appliance such that the substances are delivered to specific locations within the oral tissue while a different substance is positioned on the same appliance such that it can be delivered to a different location within the oral tissue.
10. The method of claim 1, comprising one or more modules positioned on the removable appliance to house one or more of the substances.
11. The method of claim 1, wherein the substance provides energy for treatment.
12. The method of claim 1, wherein the energy comprises electric, light, heat, sound, magnetic or electromagnetic energy.
13. The method of claim 1, comprising recharging the oral structure with an additional substance.
14. The method of claim 1, comprising
scanning a patient's dentition; and
designing one or more appliances to attach the substance to the oral structure based on the scanned dentition.
15. The method of claim 14, wherein at least one of the appliances is designed to dispense the preselected dose.
16. The method of claim 14, wherein the appliances dispense the substance in a predetermined sequence.
17. The method of claim 14, wherein at least two of the appliances dispense the substance in two or more different dosages for delivery at two or more different periods.
18. The method of claim 1, comprising
sampling an intra-oral substance; and
detecting a body condition based on the intra-oral substance
19. The method of claim 18, wherein the body condition comprises a disease.
20. The method of claim 18, comprising performing a close-loop delivery of substance based on a sampled intra-oral substance.
21. The method of claim 18, comprising transmitting the detected body condition to a remote computer for diagnosis.
22. The method of claim 1, wherein one or more of the substances accelerates tooth movement by degrading collagen and/or elastin in the oral tissue.
23. The method of claim 21, wherein one or more of the substances contains at least one of the following active ingredients: trypsin, elastase, papain, aminobenzoate potassium, cathepsin, amylolytic enzyme, proteolytic enzyme, celluloytic enzyme or lipase.
24. The method of claim 1, wherein one or more of the substances accelerates tooth movement by increasing the expression or activity of endogenous enzymes that degrade collagen and/or elastin.
25. The method of claim 24, wherein one or more of the substances contains at least one of the following active ingredients: prostaglandin E2, prostaglandin F2alpha, heparin, relaxin, conconavalen A and/or nicotine.
26. The method of claim 1, wherein one or more of the substances accelerates tooth movement by causing degradation of glycosaminoglycans or proteoglycans.
27. The method of claim 26, wherein one or more of the substances contains at least one of the following active ingredients: hyaluronidase, alpha-L-iduronidase, catabolin, or estradiol.
28. The method of claim 1, wherein one or more of the substances induces inflammation by increasing the local concentration of interleukin-1, interleukin-6, tumor necrosis factor-alpha, or transforming growth factor-beta.
29. The method of claim 1, wherein one or more of the substances prevents tooth relapse by causing an increase in the number of crosslinks between tissue matrix proteins in the oral environment.
30. The method of claim 29, wherein one or more of the substances contains at least one of the following active ingredients: genipin, carbodiimide, glutaraldehyde, formaldehyde, 1,6-diaminohexane, bioflavonoids, or reducing sugars such as glucose, ribose or derivatives thereof.
31. The method of claim 1, wherein one or more of the substances alters tooth movement by stimulating or reducing bone resorption.
32. The method of claim 1, wherein one or more of the substances contains a bisphosphoate such as risedronate or AHBuBP.
33. The method of claim 1, comprising storing a first substance in a first reservoir and a second substance in a second reservoir.
34. The method of claim 33, wherein the first substance is different from the second substance.
35. The method of claim 33, wherein the first substance is the same as the second substance.
36. The method of claim 33, comprising a third reservoir storing a third substance, wherein the first and third substances are different from the second substance.
37. The method of claim 1, wherein the substance comprises analgesics.
38. The method of claim 1, wherein the substance relieves oral pain involved with dental movement.
39. The method of claim 1, wherein the substance relieves pain from alveolar ridge augmentation and orthognathic treatment.
40. The method of claim 1, wherein the substance provides fresh breath.
US11/000,282 2004-11-30 2004-11-30 Systems and methods for intra-oral drug delivery Abandoned US20060115785A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US11/000,282 US20060115785A1 (en) 2004-11-30 2004-11-30 Systems and methods for intra-oral drug delivery
PCT/US2005/043431 WO2006060547A2 (en) 2004-11-30 2005-11-29 Systems and methods for intra-oral drug delivery
EP05852615.3A EP1824410B1 (en) 2004-11-30 2005-11-29 Systems and methods for intra-oral drug delivery
JP2007543616A JP5004295B2 (en) 2004-11-30 2005-11-29 Systems and methods for intraoral drug delivery
US11/982,301 US8075309B2 (en) 2004-11-30 2007-10-31 Systems and methods for intra-oral drug delivery
US13/324,882 US8439674B2 (en) 2004-11-30 2011-12-13 Systems and methods for intra-oral drug delivery
JP2012023628A JP2012086076A (en) 2004-11-30 2012-02-07 System and method for intra-oral drug delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/000,282 US20060115785A1 (en) 2004-11-30 2004-11-30 Systems and methods for intra-oral drug delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/982,301 Continuation US8075309B2 (en) 2004-11-30 2007-10-31 Systems and methods for intra-oral drug delivery

Publications (1)

Publication Number Publication Date
US20060115785A1 true US20060115785A1 (en) 2006-06-01

Family

ID=36565709

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/000,282 Abandoned US20060115785A1 (en) 2004-11-30 2004-11-30 Systems and methods for intra-oral drug delivery
US11/982,301 Active 2025-12-13 US8075309B2 (en) 2004-11-30 2007-10-31 Systems and methods for intra-oral drug delivery
US13/324,882 Active US8439674B2 (en) 2004-11-30 2011-12-13 Systems and methods for intra-oral drug delivery

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/982,301 Active 2025-12-13 US8075309B2 (en) 2004-11-30 2007-10-31 Systems and methods for intra-oral drug delivery
US13/324,882 Active US8439674B2 (en) 2004-11-30 2011-12-13 Systems and methods for intra-oral drug delivery

Country Status (4)

Country Link
US (3) US20060115785A1 (en)
EP (1) EP1824410B1 (en)
JP (2) JP5004295B2 (en)
WO (1) WO2006060547A2 (en)

Cited By (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074153A1 (en) 2006-12-18 2008-06-26 Electronic Dietary Foods Inc. Device for delivery of a substance
WO2008146117A1 (en) * 2007-06-01 2008-12-04 Align Technology, Inc. Method and system for providing alternating use orthodontic aligners
US20090061379A1 (en) * 2006-03-28 2009-03-05 Matsushita Electric Works, Ltd. Orthodontic Appliance
US20090184095A1 (en) * 2008-01-23 2009-07-23 Hoya Corporation Method of Connecting Pipe Members for Endoscope
US20090239188A1 (en) * 2006-06-06 2009-09-24 Reika Ortho Technologies, Inc. Changzhou Hi-Tech District Multiple Dime Transduction orthodontic devices
US20100055634A1 (en) * 2007-03-14 2010-03-04 Orthoaccel Technologies, Inc. Vibrating dental devices
US20110136070A1 (en) * 2008-03-31 2011-06-09 Orthoaccel Technologies,Inc. Vibrating compressible dental plate for correcting malocclusion
US8075309B2 (en) 2004-11-30 2011-12-13 Align Technology, Inc. Systems and methods for intra-oral drug delivery
US20120003601A1 (en) * 2009-12-15 2012-01-05 Massachusetts Institute Of Technology Jet Injector Use In Oral Evaluation
US20120219922A1 (en) * 2008-06-12 2012-08-30 Align Technology, Inc. Dental appliance
CN102755201A (en) * 2007-05-03 2012-10-31 矫正技术公司 Dental appliance wear indication and release agent receptacle
US20130252193A1 (en) * 2012-03-26 2013-09-26 Orthoaccel Technologies, Inc. Tooth positioner and vibrator combination
US20140178830A1 (en) * 2012-12-21 2014-06-26 Friedrich Widu Guidance element for a tooth
US9308326B2 (en) 2005-02-11 2016-04-12 Massachusetts Institute Of Technology Controlled needle-free transport
US9517030B2 (en) 2009-09-01 2016-12-13 Massachusetts Institute Of Technology Nonlinear system identification techniques and devices for discovering dynamic and static tissue properties
US20170007386A1 (en) * 2015-07-07 2017-01-12 Align Technology, Inc. Systems, apparatuses and methods for substance delivery from dental appliance
US9668828B2 (en) 2007-03-14 2017-06-06 Orthoaccel Technologies, Inc. Systems, methods, and adjunctive procedures for correcting malocclusion
US9730769B2 (en) 2007-05-03 2017-08-15 Align Technology, Inc. Release agent receptacle
US9968777B1 (en) * 2016-12-27 2018-05-15 Colgate-Palmolive Company Power harvesting oral device
US10183064B2 (en) 2014-03-20 2019-01-22 Technion Research & Development Foundation Limited Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof
CN109394364A (en) * 2018-10-29 2019-03-01 山东迈尔医疗科技有限公司 A kind of manufacture craft of novel 3D printing removable denture bracket
US10335250B2 (en) 2015-10-07 2019-07-02 uLab Systems, Inc. Three-dimensional printed dental appliances using lattices
US10357342B2 (en) 2016-09-21 2019-07-23 uLab Systems, Inc. Digital dental examination and documentation
US10357336B2 (en) 2015-10-07 2019-07-23 uLab Systems, Inc. Systems and methods for fabricating dental appliances or shells
US10390913B2 (en) 2018-01-26 2019-08-27 Align Technology, Inc. Diagnostic intraoral scanning
US10413385B2 (en) 2004-02-27 2019-09-17 Align Technology, Inc. Method and system for providing dynamic orthodontic assessment and treatment profiles
US10421152B2 (en) 2011-09-21 2019-09-24 Align Technology, Inc. Laser cutting
WO2019183299A1 (en) * 2018-03-21 2019-09-26 Silverman Joshua T Edentulous specific support and aesthetic restorative appliance
US10470847B2 (en) 2016-06-17 2019-11-12 Align Technology, Inc. Intraoral appliances with sensing
US10500019B2 (en) 2007-03-14 2019-12-10 Orthoaccel Technologies, Inc. System and method for correcting malocclusion
US10504386B2 (en) 2015-01-27 2019-12-10 Align Technology, Inc. Training method and system for oral-cavity-imaging-and-modeling equipment
US10509838B2 (en) 2016-07-27 2019-12-17 Align Technology, Inc. Methods and apparatuses for forming a three-dimensional volumetric model of a subject's teeth
US10517482B2 (en) 2017-07-27 2019-12-31 Align Technology, Inc. Optical coherence tomography for orthodontic aligners
US10524881B2 (en) 2010-04-30 2020-01-07 Align Technology, Inc. Patterned dental positioning appliance
US10537405B2 (en) 2014-11-13 2020-01-21 Align Technology, Inc. Dental appliance with cavity for an unerupted or erupting tooth
US10543064B2 (en) 2008-05-23 2020-01-28 Align Technology, Inc. Dental implant positioning
US10548690B2 (en) 2015-10-07 2020-02-04 uLab Systems, Inc. Orthodontic planning systems
US10548700B2 (en) 2016-12-16 2020-02-04 Align Technology, Inc. Dental appliance etch template
US10595966B2 (en) 2016-11-04 2020-03-24 Align Technology, Inc. Methods and apparatuses for dental images
US10610332B2 (en) 2012-05-22 2020-04-07 Align Technology, Inc. Adjustment of tooth position in a virtual dental model
US10613515B2 (en) 2017-03-31 2020-04-07 Align Technology, Inc. Orthodontic appliances including at least partially un-erupted teeth and method of forming them
US10624717B2 (en) 2015-10-07 2020-04-21 Ulab Systems Inc. Tooth modeling system
US10631953B2 (en) 2015-10-07 2020-04-28 uLab Systems, Inc. Three-dimensional printed dental appliances using support structures
US10639134B2 (en) 2017-06-26 2020-05-05 Align Technology, Inc. Biosensor performance indicator for intraoral appliances
US10758321B2 (en) 2008-05-23 2020-09-01 Align Technology, Inc. Smile designer
US10779718B2 (en) 2017-02-13 2020-09-22 Align Technology, Inc. Cheek retractor and mobile device holder
US10813720B2 (en) 2017-10-05 2020-10-27 Align Technology, Inc. Interproximal reduction templates
US10885521B2 (en) 2017-07-17 2021-01-05 Align Technology, Inc. Method and apparatuses for interactive ordering of dental aligners
US10893918B2 (en) 2012-03-01 2021-01-19 Align Technology, Inc. Determining a dental treatment difficulty
US10919209B2 (en) 2009-08-13 2021-02-16 Align Technology, Inc. Method of forming a dental appliance
US10952821B2 (en) 2016-09-21 2021-03-23 uLab Systems, Inc. Combined orthodontic movement of teeth with temporomandibular joint therapy
US10980613B2 (en) 2017-12-29 2021-04-20 Align Technology, Inc. Augmented reality enhancements for dental practitioners
CN112739288A (en) * 2018-09-24 2021-04-30 3M创新有限公司 Dental appliance with cosmetic therapeutic aqueous solution
US10993783B2 (en) 2016-12-02 2021-05-04 Align Technology, Inc. Methods and apparatuses for customizing a rapid palatal expander
US11026831B2 (en) 2016-12-02 2021-06-08 Align Technology, Inc. Dental appliance features for speech enhancement
US11026768B2 (en) 1998-10-08 2021-06-08 Align Technology, Inc. Dental appliance reinforcement
US11045283B2 (en) 2017-06-09 2021-06-29 Align Technology, Inc. Palatal expander with skeletal anchorage devices
US11083545B2 (en) 2009-03-19 2021-08-10 Align Technology, Inc. Dental wire attachment
WO2021161123A1 (en) * 2020-02-12 2021-08-19 Americo Fernandes Multi-function oral appliance
US11096763B2 (en) 2017-11-01 2021-08-24 Align Technology, Inc. Automatic treatment planning
US11103330B2 (en) 2015-12-09 2021-08-31 Align Technology, Inc. Dental attachment placement structure
US11109946B2 (en) 2019-09-16 2021-09-07 Align Technology, Inc. Durable ornamental indicia carrier
US11116605B2 (en) 2017-08-15 2021-09-14 Align Technology, Inc. Buccal corridor assessment and computation
US11123156B2 (en) 2017-08-17 2021-09-21 Align Technology, Inc. Dental appliance compliance monitoring
US11134676B2 (en) 2017-08-30 2021-10-05 Nobio Ltd. Anti-microbial particles and methods of use thereof
CN113499534A (en) * 2021-08-11 2021-10-15 牡丹江医学院 Fixed-point nursing device for dental ulcer
US20210353387A1 (en) * 2018-10-18 2021-11-18 3M Innovative Properties Company Dental appliance with structured surface
US11178867B2 (en) 2016-02-25 2021-11-23 Nobio Ltd. Micro and nanoparticulate compositions comprising anti-microbially active groups
US11213368B2 (en) 2008-03-25 2022-01-04 Align Technology, Inc. Reconstruction of non-visible part of tooth
US11219506B2 (en) 2017-11-30 2022-01-11 Align Technology, Inc. Sensors for monitoring oral appliances
US20220031426A1 (en) * 2020-07-31 2022-02-03 Align Technology, Inc. Direct fabrication of mixed metal and polymer orthodontic devices
US11273011B2 (en) 2016-12-02 2022-03-15 Align Technology, Inc. Palatal expanders and methods of expanding a palate
CN114391985A (en) * 2021-12-27 2022-04-26 四川大学 Bracket-free invisible orthodontic base station utilizing dental implant anchorage
US11364098B2 (en) 2016-09-21 2022-06-21 uLab Systems, Inc. Combined orthodontic movement of teeth with airway development therapy
US11376101B2 (en) 2016-12-02 2022-07-05 Align Technology, Inc. Force control, stop mechanism, regulating structure of removable arch adjustment appliance
US11419702B2 (en) 2017-07-21 2022-08-23 Align Technology, Inc. Palatal contour anchorage
US11426259B2 (en) 2012-02-02 2022-08-30 Align Technology, Inc. Identifying forces on a tooth
US11432908B2 (en) 2017-12-15 2022-09-06 Align Technology, Inc. Closed loop adaptive orthodontic treatment methods and apparatuses
US11436191B2 (en) 2007-11-08 2022-09-06 Align Technology, Inc. Systems and methods for anonymizing patent images in relation to a clinical data file
US11471250B2 (en) 2010-04-30 2022-10-18 Align Technology, Inc. Reinforced aligner hooks
US11471252B2 (en) 2008-10-08 2022-10-18 Align Technology, Inc. Dental positioning appliance having mesh portion
US11504214B2 (en) 2018-05-11 2022-11-22 Align Technology, Inc. Devices, systems, and computer-implemented methods for dental attachment templates
US11514199B2 (en) 2007-10-12 2022-11-29 Align Technology, Inc. Prosthodontic and orthodontic apparatus and methods
US11534974B2 (en) 2017-11-17 2022-12-27 Align Technology, Inc. Customized fabrication of orthodontic retainers based on patient anatomy
US11534268B2 (en) 2017-10-27 2022-12-27 Align Technology, Inc. Alternative bite adjustment structures
US11554000B2 (en) 2015-11-12 2023-01-17 Align Technology, Inc. Dental attachment formation structure
US20230018058A1 (en) * 2015-07-07 2023-01-19 Align Technology, Inc. Appliances for intraoral delivery of agents
US11564777B2 (en) 2018-04-11 2023-01-31 Align Technology, Inc. Releasable palatal expanders
US11576752B2 (en) 2017-10-31 2023-02-14 Align Technology, Inc. Dental appliance having selective occlusal loading and controlled intercuspation
US11583365B2 (en) 2015-10-07 2023-02-21 uLab Systems, Inc. System and methods for tooth movement as a flock
US11589954B2 (en) 2004-02-24 2023-02-28 Align Technology, Inc. Method and system for designing and producing dental prosthesis and appliances
US11589956B2 (en) 2018-01-26 2023-02-28 Align Technology, Inc. Visual prosthetic and orthodontic treatment planning
US11596502B2 (en) 2015-12-09 2023-03-07 Align Technology, Inc. Dental attachment placement structure
US11602414B2 (en) 2019-06-11 2023-03-14 Align Technology, Inc. Aligner material, cleanliness, and quality detection via aligner case
US11612455B2 (en) 2016-06-17 2023-03-28 Align Technology, Inc. Orthodontic appliance performance monitor
US11612454B2 (en) 2010-04-30 2023-03-28 Align Technology, Inc. Individualized orthodontic treatment index
US11633268B2 (en) 2017-07-27 2023-04-25 Align Technology, Inc. Tooth shading, transparency and glazing
US11638629B2 (en) 2014-09-19 2023-05-02 Align Technology, Inc. Arch expanding appliance
US11648090B2 (en) 2012-05-14 2023-05-16 Align Technology, Inc. Multilayer polymer sheets
US11654004B2 (en) 2008-07-17 2023-05-23 Align Technology, Inc. Methods, systems and accessories useful for procedures relating to dental implants
US11661468B2 (en) 2020-08-27 2023-05-30 Align Technology, Inc. Additive manufacturing using variable temperature-controlled resins
US11701203B2 (en) 2018-06-29 2023-07-18 Align Technology, Inc. Dental appliance hook placement and visualization
US11717384B2 (en) 2007-05-25 2023-08-08 Align Technology, Inc. Dental appliance with eruption tabs
US11718019B2 (en) 2018-09-14 2023-08-08 Align Technology, Inc. System for hybrid 3D printing with photo-curable materials
US11723748B2 (en) 2019-12-23 2023-08-15 Align Technology, Inc. 2D-to-3D tooth reconstruction, optimization, and positioning frameworks using a differentiable renderer
US11744678B2 (en) 2014-08-22 2023-09-05 Align Technology, Inc. Attachment structure
US11744677B2 (en) 2014-09-19 2023-09-05 Align Technology, Inc. Arch adjustment appliance
US11752030B2 (en) 2015-01-13 2023-09-12 Align Technology, Inc. Systems and methods for positioning a patient's mandible in response to sleep apnea status
US11771531B2 (en) 2015-01-13 2023-10-03 Align Technology, Inc. Mandibular advancement and retraction via bone anchoring devices
US11771527B2 (en) 2019-02-20 2023-10-03 Sdc U.S. Smilepay Spv Limited wear aligner and treatment methods
US11786341B2 (en) 2019-12-09 2023-10-17 Align Technology, Inc. Occlusal block design for lateral locking
US11793608B2 (en) 2017-11-01 2023-10-24 Align Technology, Inc. Systems and methods for correcting malocclusions of teeth
US11793667B2 (en) 2015-01-13 2023-10-24 Align Technology, Inc. Systems, methods, and devices for applying distributed forces for mandibular advancement
US11845868B2 (en) 2020-03-13 2023-12-19 Align Technology, Inc. Weak covalent crosslinks in thermoset materials for increased toughness
US11851510B2 (en) 2020-03-02 2023-12-26 Align Technology, Inc. Low viscosity photo-curable resins for the direct fabrication of orthodontic appliances
US11931222B2 (en) 2015-11-12 2024-03-19 Align Technology, Inc. Dental attachment formation structures

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553157B2 (en) 2004-09-24 2009-06-30 Align Technology, Inc. Systems and methods for dental appliance compliance indication
US20050053895A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Attention: Chief Patent Counsel Illuminated electric toothbrushes emitting high luminous intensity toothbrush
WO2007146841A2 (en) * 2006-06-09 2007-12-21 The Board Of Trustees Of The University Of Illinois Collagen cross-linking agents on dental restorative treatment and preventive dentistry
WO2008124009A2 (en) * 2007-04-02 2008-10-16 The Cleveland Clinic Foundation Treating glaucoma
MX2010005004A (en) * 2008-02-08 2010-05-27 Colgate Palmolive Co Compositions and devices.
DE102008055551B4 (en) * 2008-12-19 2018-01-11 Roman Zolow implant
WO2010093632A1 (en) * 2009-02-10 2010-08-19 Orthoaccel Technologies, Inc. Vibrating dental plate and accessories
WO2011146978A1 (en) * 2010-05-25 2011-12-01 International Scientific Pty Ltd Delivery of oral care products
JP6046609B2 (en) 2010-06-17 2016-12-21 インターナショナル・サイエンティフィック・プロプライエタリー・リミテッド Delivery of skin care products
US20110114100A1 (en) * 2010-06-23 2011-05-19 Ramiro Michael Alvarez P3 Personal Power and Performance Mouthpiece
US11129746B2 (en) 2010-06-23 2021-09-28 Dental Choice Holdings Llc Method and oral appliance for improving air intake and reducing bruxism
US9968419B2 (en) * 2010-06-23 2018-05-15 Ramiro Michael Alvarez Method and oral appliance for improving air intake and reducing bruxism
GB201113041D0 (en) * 2011-07-28 2011-09-14 King S College London Mouth guard
WO2013060563A1 (en) * 2011-10-25 2013-05-02 Universität Bern Device for treating gingiva/ mucosa at teeth or implants
US9022781B2 (en) 2012-02-15 2015-05-05 Align Technology, Inc. Orthodontic appliances that accommodate incremental and continuous tooth movement, systems and methods
US9462822B2 (en) 2012-11-13 2016-10-11 Elwha Llc Oral implant system for releasing encapsulated food additives by exposure to energy
US9357865B2 (en) 2012-11-13 2016-06-07 Elwha Llc Actively released food additives
US9750361B2 (en) 2012-11-13 2017-09-05 Elwha Llc Odorant-releasing utensil
JP6306604B2 (en) * 2012-11-14 2018-04-04 ジフォマ ゲゼルシャフト ミット ベシュレンクテル ハフツング Treatment element for dental implant and treatment system using the treatment element
US10260968B2 (en) 2013-03-15 2019-04-16 Nano Composite Products, Inc. Polymeric foam deformation gauge
KR101958156B1 (en) 2013-03-15 2019-03-13 나노 컴포지트 프로덕츠, 인코포레이티드 Composite material used as a strain gauge
US20150132707A1 (en) * 2013-09-11 2015-05-14 Ormco Corporation Braces to aligner transition in orthodontic treatment
CN105873631B (en) * 2013-11-05 2021-06-18 辛纳吉勒公司 Device and method for continuous drug delivery via the oral cavity
US9937018B2 (en) * 2013-12-11 2018-04-10 Martin G. Martz Tooth positioning appliance with curved interconnecting elements
US11642198B2 (en) 2014-06-20 2023-05-09 Align Technology, Inc. Elastic-coated orthodontic appliance
CN115300137A (en) 2014-01-31 2022-11-08 阿莱恩技术有限公司 Orthodontic appliance with elastic body
US10555792B2 (en) 2014-01-31 2020-02-11 Align Technology, Inc. Direct fabrication of orthodontic appliances with elastics
CN115068134A (en) 2014-03-21 2022-09-20 阿莱恩技术有限公司 Segmented orthodontic appliances with elastics
WO2015158825A1 (en) * 2014-04-17 2015-10-22 Kamber Michael Means and methods for preventing or treating dental implant associated inflammation
EP2949288A1 (en) * 2014-05-27 2015-12-02 Dentsply Implants Manufacturing GmbH Treatment abutment and method for producing the same
CN111631832B (en) 2014-06-20 2022-02-25 阿莱恩技术有限公司 Orthotic with elastic layer
US9504848B2 (en) * 2014-07-18 2016-11-29 Dabney Patents, L.L.C. Medical devices with a light source and antimicrobial solution
US9931189B2 (en) * 2014-07-18 2018-04-03 Dabney Patents, L.L.C. Veterinary devices with a light source and antimicrobial solution
US9579177B2 (en) * 2014-07-18 2017-02-28 Dabney Patents, L.L.C. Dental and medical devices with light source and antimicrobial solution
US9700735B2 (en) * 2014-07-18 2017-07-11 Dabney Patents, L.L.C. Medical and veterinary applications of light to antimicrobial and antineoplastic chemicals
US9857246B2 (en) 2014-09-17 2018-01-02 Sensable Technologies, Llc Sensing system including a sensing membrane
WO2016112229A1 (en) 2015-01-07 2016-07-14 Nano Composite Products, Inc. Shoe-based analysis system
US20180000574A1 (en) * 2015-01-22 2018-01-04 Americo Fernandes Dental Appliances
EP3291872A4 (en) 2015-05-06 2019-02-13 SynAgile Corporation Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
JP6375448B2 (en) * 2015-06-10 2018-08-15 秀俊 西尾 Intraoral vibration imparting device
US11571278B2 (en) 2015-07-07 2023-02-07 Align Technology, Inc. Systems, apparatuses and methods for dental appliances with integrally formed features
US10959810B2 (en) 2015-07-07 2021-03-30 Align Technology, Inc. Direct fabrication of aligners for palate expansion and other applications
US11045282B2 (en) 2015-07-07 2021-06-29 Align Technology, Inc. Direct fabrication of aligners with interproximal force coupling
US10874483B2 (en) 2015-07-07 2020-12-29 Align Technology, Inc. Direct fabrication of attachment templates with adhesive
US10743964B2 (en) 2015-07-07 2020-08-18 Align Technology, Inc. Dual aligner assembly
WO2017006178A1 (en) 2015-07-07 2017-01-12 Align Technology, Inc. Systems, apparatuses and methods for substance delivery from dental appliances and for ornamental designs on dental appliances
US10328225B2 (en) 2015-10-20 2019-06-25 Garner Geniothrust Llc Dental appliance apparatus and respiratory performance
WO2017182425A1 (en) 2016-04-20 2017-10-26 Grünenthal GmbH Pharmaceutical dosage form mountable to a tooth
JP6781427B2 (en) * 2016-05-24 2020-11-04 学校法人日本大学 Tooth relapse inhibitor containing daidzein as an active ingredient
DE102017009287B4 (en) * 2017-10-06 2019-07-11 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Orthodontic dentifrice and method of making the same
EP3737333A4 (en) * 2018-01-09 2021-11-03 E2Bio Life Sciences, Llc Method and device for the enhancement of topical treatments for oral mucositis and other oral conditions
US20200066391A1 (en) * 2018-08-24 2020-02-27 Rohit C. Sachdeva Patient -centered system and methods for total orthodontic care management
JP2022509622A (en) * 2018-11-19 2022-01-21 スリーエム イノベイティブ プロパティズ カンパニー Dental equipment with ion exchange coating
CN109498190A (en) * 2018-12-29 2019-03-22 合肥常春藤齿科器材有限公司 A kind of dental aligners convenient for cleaning tooth
US11285035B2 (en) 2019-07-19 2022-03-29 Dental Choice Holdings Llc Single arch dental device and method of manufacture
WO2021092405A1 (en) * 2019-11-08 2021-05-14 Emanate Biomedical Inc. Oral appliance for treating inflamed tissue of the oral cavity using the top-down method
EP3954321A1 (en) * 2020-08-14 2022-02-16 Bottmedical AG Process for fabricating a dental appliance and non-therapeutical use of a dental appliance
US11458220B2 (en) 2020-11-12 2022-10-04 Singletto Inc. Microbial disinfection for personal protection equipment
WO2022195430A1 (en) * 2021-03-17 2022-09-22 Rezadoost Mohammad Hossein System for denture cleaning and drug injection into a patient's mouth
WO2023181741A1 (en) * 2022-03-23 2023-09-28 ソニーセミコンダクタソリューションズ株式会社 Sensor module, mouthpiece-type device, and system

Citations (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215706A (en) * 1978-10-13 1980-08-05 Loew's Theatres, Inc. Nicotine transfer process
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4834110A (en) * 1988-02-01 1989-05-30 Richard Patricia A Suction clamped treatment cup saliva sampler
US4846165A (en) * 1986-11-26 1989-07-11 Dentsply Research & Development Corp. Wound dressing membrane
US4861268A (en) * 1988-06-13 1989-08-29 Transpharm Group Tooth-anchored beneficial agent delivery device
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4892736A (en) * 1983-10-07 1990-01-09 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4990089A (en) * 1988-08-23 1991-02-05 Dunhall Pharmaceuticals, Inc. Method and material for brightening teeth
US5080583A (en) * 1990-11-23 1992-01-14 Hunting Tanya L Fragranced orthodontic appliance and method of making
US5098711A (en) * 1988-11-14 1992-03-24 Ira Hill Method of treating the oral cavity with dental floss containing chemotherapeutic agents
US5098363A (en) * 1989-12-11 1992-03-24 Pressware International, Inc. Precise positioning of blank in die
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
US5139768A (en) * 1989-01-31 1992-08-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental composition for hypersensitive teeth
US5194003A (en) * 1988-06-13 1993-03-16 Transpharm Group, Inc. Removable device for delivering beneficial agents orally
US5234342A (en) * 1990-03-22 1993-08-10 Ultradent Products, Inc. Sustained release method for treating teeth surfaces
US5240415A (en) * 1990-06-07 1993-08-31 Haynie Michel B Dental bleach system having separately compartmented fumed silica and hydrogen peroxide and method of using
US5330746A (en) * 1988-05-03 1994-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental varnish composition, and method of use
US5409631A (en) * 1990-03-22 1995-04-25 Ultradent Products Dental bleaching compositions and methods for bleaching teeth surfaces
US5433952A (en) * 1992-05-04 1995-07-18 Digestive Care Inc. Intraoral medicament-releasing device
US5438076A (en) * 1988-05-03 1995-08-01 Perio Products, Ltd. Liquid polymer composition, and method of use
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5513630A (en) * 1995-03-08 1996-05-07 Century; Theodore J. Powder dispenser
US5534524A (en) * 1994-05-09 1996-07-09 Board Of Regents, The University Of Texas System Suppression of bone resorption by quinolines
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
US5711935A (en) * 1994-05-10 1998-01-27 Whitehill Oral Technologies, Inc. Dental floss
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5725843A (en) * 1990-03-22 1998-03-10 Ultradent Products, Inc. Methods for bleaching teeth surfaces
US5745598A (en) * 1994-03-11 1998-04-28 Shaw; Venson Ming Heng Statistics based segmentation and parameterization method for dynamic processing, identification, and verification of binary contour image
US5855870A (en) * 1990-03-22 1999-01-05 Ultradent Products, Inc. Method for treating sensitive teeth
US5861298A (en) * 1996-06-17 1999-01-19 Smithkline Beecham Corporation Cathepsin K gene
US5865332A (en) * 1998-04-27 1999-02-02 Northern Telecom Limited Environmental protection housing
US5866432A (en) * 1995-04-12 1999-02-02 Oy Medix Biochemica Ab Methods for diagnosis of periodontal diseases
US5895360A (en) * 1996-06-26 1999-04-20 Medtronic, Inc. Gain control for a periodic signal and method regarding same
US5904718A (en) * 1986-03-27 1999-05-18 Biocoll Laboratories, Inc. Delayed drug delivery system
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US5945404A (en) * 1993-09-29 1999-08-31 Nissin Shokuhin Kabushiki Kaisha 21-Substituted steroid compound
US5944680A (en) * 1996-06-26 1999-08-31 Medtronic, Inc. Respiratory effort detection method and apparatus
US5954869A (en) * 1997-05-07 1999-09-21 Bioshield Technologies, Inc. Water-stabilized organosilane compounds and methods for using the same
US6021352A (en) * 1996-06-26 2000-02-01 Medtronic, Inc, Diagnostic testing methods and apparatus for implantable therapy devices
US6036494A (en) * 1998-04-03 2000-03-14 Cohen; Morton Method for cosmetically improving and altering the appearance of teeth
US6036943A (en) * 1990-03-22 2000-03-14 Ultradent Products, Inc. Methods for treating a person's teeth using sticky dental compositions in combination with passive-type dental trays
US6072100A (en) * 1998-01-28 2000-06-06 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US6074674A (en) * 1997-10-31 2000-06-13 University Of Kentucky Research Foundation Formulations for sustained-release of topical anesthetics and methods of making and using same
US6093084A (en) * 1988-08-01 2000-07-25 Dentsply Research & Development Corp. Device and method for dispensing polymerizable compositions
US6099479A (en) * 1996-06-26 2000-08-08 Medtronic, Inc. Method and apparatus for operating therapy system
US6109916A (en) * 1997-10-03 2000-08-29 Wilcko; M. Thomas Orthodontic method and device
US6132384A (en) * 1996-06-26 2000-10-17 Medtronic, Inc. Sensor, method of sensor implant and system for treatment of respiratory disorders
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
US6206920B1 (en) * 1996-05-13 2001-03-27 Ben-Gurion University Of The Negev Composition and method for forming biodegradable implants in situ and uses of these implants
US6210163B1 (en) * 1998-04-03 2001-04-03 Morton Cohen Composition and method for cosmetically improving and altering the appearance of teeth
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
US6267590B1 (en) * 1999-11-24 2001-07-31 Agion Technologies, Llc Antimicrobial dental products
US6287120B1 (en) * 1998-12-04 2001-09-11 Peter E. Wiesel Methods and apparatus for treating teeth
US20020004065A1 (en) * 2000-01-20 2002-01-10 David Kanios Compositions and methods to effect the release profile in the transdermal administration of active agents
US6368576B1 (en) * 1998-11-12 2002-04-09 Ultradent Products, Inc. Methods for bleaching, opacifying and desensitizing teeth
US6372543B1 (en) * 1997-12-19 2002-04-16 Stmicroelectronics, Inc. Wrap-around interconnect for fine pitch ball grid array
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
US20030003421A1 (en) * 2001-07-02 2003-01-02 Thierry Bestenheider Pre-impregnated disposable dental substance delivery mouthpiece
US6503539B2 (en) * 1998-02-27 2003-01-07 Biora Bioex Ab Matrix protein compositions for wound healing
US6503955B1 (en) * 1999-09-11 2003-01-07 The Procter & Gamble Company Pourable liquid vehicles
US6509028B2 (en) * 2000-06-26 2003-01-21 Epicept Corporation Methods and compositions for treating pain of the mucous membrane
US6528555B1 (en) * 2000-10-12 2003-03-04 3M Innovative Properties Company Adhesive for use in the oral environment having color-changing capabilities
US6562363B1 (en) * 1997-09-26 2003-05-13 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6573282B1 (en) * 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6589050B1 (en) * 1998-10-21 2003-07-08 Paul W. Mackey Fragranced orthodontic appliances and method of forming same
US6607382B1 (en) * 2000-09-21 2003-08-19 Align Technology, Inc. Methods and systems for concurrent tooth repositioning and substance delivery
US6607387B2 (en) * 2000-10-30 2003-08-19 Healthetech, Inc. Sensor system for diagnosing dental conditions
US6616444B2 (en) * 1992-11-09 2003-09-09 Ormco Corporation Custom orthodontic appliance forming method and apparatus
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US20040023853A1 (en) * 2002-05-23 2004-02-05 Peri Krishna G. Antagonistic peptides of prostaglandin E2 receptor subtype EP4
US6692771B2 (en) * 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
US6699384B1 (en) * 1999-09-21 2004-03-02 Battelle Memorial Institute Compact electrochemical sensor system and method for field testing for metals in saliva or other fluids
US6729878B2 (en) * 1998-04-03 2004-05-04 Morton Cohen Composition and method for improving, altering, and treating teeth
US6736980B2 (en) * 2000-11-22 2004-05-18 Pti Technologies, Inc. Prognostic health monitoring of fluidic systems using MEMS technology
US20040101801A1 (en) * 2000-09-22 2004-05-27 Mao Jeremy Jian Use of cyclic forces to expedite remodeling of craniofacial bones
US20040115587A1 (en) * 2002-11-01 2004-06-17 Bas Medical, Inc. Methods and systems for enabling and stabilizing tooth movement
US20040115137A1 (en) * 2002-12-17 2004-06-17 Verrall Andrew P. Water-soluble film for oral administration
US6772026B2 (en) * 2000-04-05 2004-08-03 Therics, Inc. System and method for rapidly customizing design, manufacture and/or selection of biomedical devices
US20050095561A1 (en) * 2002-05-03 2005-05-05 Reinhard Schatzner Device for applying dental treatment agent to teeth and/or gums
US20050119723A1 (en) * 2003-11-28 2005-06-02 Medlogics Device Corporation Medical device with porous surface containing bioerodable bioactive composites and related methods
US6916463B2 (en) * 2002-09-24 2005-07-12 The Procter & Gamble Company Oral products having an aesthetic layer
US20050152850A1 (en) * 2004-01-09 2005-07-14 Engebretson Steven P. Methods and compositions for facilitating metabolic control
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance

Family Cites Families (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US521625A (en) * 1894-06-19 Device for affixing postage or other stamps to envelopes
US3407500A (en) 1966-05-06 1968-10-29 Peter C. Kesling Tooth positioner
US3503127A (en) 1968-12-24 1970-03-31 Simon Kasdin Denture with a receptacle therein
US3660900A (en) 1969-11-10 1972-05-09 Lawrence F Andrews Method and apparatus for improved orthodontic bracket and arch wire technique
US3600808A (en) 1970-01-22 1971-08-24 James Jackson Reeve Anterior root-torquing auxiliary wire
US3665770A (en) 1970-07-24 1972-05-30 Bio Medical Sciences Inc Temperature indicator
US3860803A (en) 1970-08-24 1975-01-14 Diecomp Inc Automatic method and apparatus for fabricating progressive dies
US3683502A (en) 1970-09-14 1972-08-15 Melvin Wallshein Orthodontic systems
US3704985A (en) 1971-03-04 1972-12-05 Bio Medical Sciences Inc Temperature indicator
US3742942A (en) * 1971-03-30 1973-07-03 J Westline Method and means for cleansing teeth and their gingival crevices
US3733905A (en) 1971-09-02 1973-05-22 N Bremer Chemical thermometer and holder
US3916526A (en) 1973-05-10 1975-11-04 Fred Frank Schudy Method and apparatus for orthodontic treatment
US3874084A (en) * 1973-12-06 1975-04-01 Greene Orville N Prescription tooth-cleansing and gingival therapeutic device
US3848335A (en) 1974-01-25 1974-11-19 E Bergersen Orthodontic appliance having cooperation detection capability
US3922786A (en) 1974-01-30 1975-12-02 Joseph L Lavin Method and apparatus for forming and fitting orthodontic appliances
US3968690A (en) 1975-02-12 1976-07-13 Michel Blouin Combined infant pacifier and thermometer
US3950851A (en) 1975-03-05 1976-04-20 Bergersen Earl Olaf Orthodontic positioner and method for improving retention of tooth alignment therewith
JPS5358191A (en) 1976-11-05 1978-05-25 Osamu Yoshii Method of producing dental correction treating instrument using silicon resin material
US4324547A (en) 1978-09-16 1982-04-13 Vishay Intertechnology, Inc. Dentistry technique
US4253828A (en) 1979-04-09 1981-03-03 Coles Donna C Orthodontic appliance
DE2936847A1 (en) 1979-09-12 1981-03-19 Paul Dr. 6054 Rodgau Heitlinger METHOD FOR PRODUCING DENTAL SPARE AND DEVICE FOR IMPLEMENTING THE METHOD
US4447164A (en) 1982-02-22 1984-05-08 Trp Energy Sensors, Inc. Temperature-responsive pacifier assembly
US4500294A (en) 1983-10-03 1985-02-19 Epic International Corporation Method and device for detecting dental cavities
US4526540A (en) 1983-12-19 1985-07-02 Dellinger Eugene L Orthodontic apparatus and method for treating malocclusion
US4798534A (en) 1984-08-03 1989-01-17 Great Lakes Orthodontic Laboratories Inc. Method of making a dental appliance
US4629424A (en) * 1984-08-30 1986-12-16 Integrated Ionics, Inc. Intraoral ambient sensing device
US4609349A (en) 1984-09-24 1986-09-02 Cain Steve B Active removable orthodontic appliance and method of straightening teeth
US4591341A (en) 1984-10-03 1986-05-27 Andrews Lawrence F Orthodontic positioner and method of manufacturing same
US4611992A (en) * 1984-11-02 1986-09-16 Oddvin Lokken Spray guard for dental tool
US4664626A (en) 1985-03-19 1987-05-12 Kesling Peter C System for automatically preventing overtipping and/or overuprighting in the begg technique
US4629429A (en) 1985-10-15 1986-12-16 Tsuyoshi Horie Abacus with each counter held in position by friction or magnetic attraction
US4936862A (en) 1986-05-30 1990-06-26 Walker Peter S Method of designing and manufacturing a human joint prosthesis
US4713243A (en) 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
CH672722A5 (en) 1986-06-24 1989-12-29 Marco Brandestini
CA1284040C (en) 1986-06-26 1991-05-14 Peter C. Kesling Edgewise bracket to provide both free crown tipping and a predetermineddegree of root uprighting
US4877398A (en) 1987-04-16 1989-10-31 Tp Orthodontics, Inc. Bracket for permitting tipping and limiting uprighting
US4676747A (en) 1986-08-06 1987-06-30 Tp Orthodontics, Inc. Torquing auxiliary
JPH0714401B2 (en) 1986-08-13 1995-02-22 而至歯科工業株式会社 Dental tray
US4983334A (en) 1986-08-28 1991-01-08 Loren S. Adell Method of making an orthodontic appliance
US4976954A (en) 1986-12-02 1990-12-11 Purdue Research Foundation Anticariogenic compositions
US5064640A (en) 1986-12-02 1991-11-12 Purdue Research Foundation Anticariogenic compositions
US4755139A (en) 1987-01-29 1988-07-05 Great Lakes Orthodontics, Ltd. Orthodontic anchor appliance and method for teeth positioning and method of constructing the appliance
US4787845A (en) * 1987-03-16 1988-11-29 Valentine Rodney F Oral irrigator
US4850865A (en) 1987-04-30 1989-07-25 Napolitano John R Orthodontic method and apparatus
US4856991A (en) 1987-05-05 1989-08-15 Great Lakes Orthodontics, Ltd. Orthodontic finishing positioner and method of construction
US5186623A (en) 1987-05-05 1993-02-16 Great Lakes Orthodontics, Ltd. Orthodontic finishing positioner and method of construction
US4836778A (en) 1987-05-26 1989-06-06 Vexcel Corporation Mandibular motion monitoring system
US4793803A (en) 1987-10-08 1988-12-27 Martz Martin G Removable tooth positioning appliance and method
US4880380A (en) 1987-10-13 1989-11-14 Martz Martin G Orthodonture appliance which may be manually installed and removed by the patient
US4978391A (en) 1987-11-13 1990-12-18 Dentsply Management Corp. Intraoral medicament delivery and procedure
US5160737A (en) 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US4941826A (en) 1988-06-09 1990-07-17 William Loran Apparatus for indirect dental machining
US5100316A (en) 1988-09-26 1992-03-31 Wildman Alexander J Orthodontic archwire shaping method
US5055039A (en) 1988-10-06 1991-10-08 Great Lakes Orthodontics, Ltd. Orthodontic positioner and methods of making and using same
US5165913A (en) 1988-11-14 1992-11-24 Ira Hill Controlled release interproximal delivery system
US5011405A (en) 1989-01-24 1991-04-30 Dolphin Imaging Systems Method for determining orthodontic bracket placement
US5137449A (en) 1989-03-20 1992-08-11 Johnson & Johnson Consumer Products, Inc. Intraoral medication releasing system
JPH039712U (en) 1989-06-20 1991-01-30
US4968251A (en) 1989-07-03 1990-11-06 Darnell Daniel H Treatment of a tooth
US5356291A (en) 1989-07-03 1994-10-18 Dunhall Pharmaceuticals, Inc. Treatment of a tooth
WO1991002518A1 (en) 1989-08-25 1991-03-07 Bioglan Laboratories Ltd. Pharmaceutical compositions and a device for administering the same
IE903302A1 (en) 1989-09-15 1991-04-10 Pehrom Pharmaceutical Corp Topical preparation for treatment of aphthous ulcers and¹other lesions
US5129824A (en) * 1989-12-21 1992-07-14 Keller Duane C Method for treating periodontal disease
US5474448A (en) 1990-01-19 1995-12-12 Ormco Corporation Low profile orthodontic appliance
US5139419A (en) 1990-01-19 1992-08-18 Ormco Corporation Method of forming an orthodontic brace
US5447432A (en) 1990-01-19 1995-09-05 Ormco Corporation Custom orthodontic archwire forming method and apparatus
US5395238A (en) 1990-01-19 1995-03-07 Ormco Corporation Method of forming orthodontic brace
US5368478A (en) 1990-01-19 1994-11-29 Ormco Corporation Method for forming jigs for custom placement of orthodontic appliances on teeth
US5533895A (en) 1990-01-19 1996-07-09 Ormco Corporation Orthodontic appliance and group standardized brackets therefor and methods of making, assembling and using appliance to straighten teeth
US5454717A (en) 1990-01-19 1995-10-03 Ormco Corporation Custom orthodontic brackets and bracket forming method and apparatus
US5431562A (en) 1990-01-19 1995-07-11 Ormco Corporation Method and apparatus for designing and forming a custom orthodontic appliance and for the straightening of teeth therewith
US5851512A (en) 1990-03-22 1998-12-22 Ultradent Products, Inc. Dental compositions having a sticky matrix material for treating sensitive teeth
US5985249A (en) 1990-03-22 1999-11-16 Ultradent Products, Inc. Sticky dental compositions for adhering a passive-type dental tray over a person's teeth
US5074786A (en) 1990-03-30 1991-12-24 Johnson & Johnson Consumer Products, Inc. Intraoral medication releasing system
US5127903A (en) 1990-05-22 1992-07-07 Mailot Kevin G Device for dispensing medicaments to infants
US5452219A (en) 1990-06-11 1995-09-19 Dentsply Research & Development Corp. Method of making a tooth mold
US5165424A (en) 1990-08-09 1992-11-24 Silverman Harvey N Method and system for whitening teeth
US5340309A (en) 1990-09-06 1994-08-23 Robertson James G Apparatus and method for recording jaw motion
US5076791A (en) 1990-10-22 1991-12-31 Madray Jr George Professional home method for bleaching teeth
US5085585A (en) * 1991-02-05 1992-02-04 Zimble Alan W Dental medicament applicator and method of use
US5326685A (en) 1991-02-13 1994-07-05 Gaglio Thomas J Viscous fluid dispensing apparatus
US5145364A (en) 1991-05-15 1992-09-08 M-B Orthodontics, Inc. Removable orthodontic appliance
US5219625A (en) 1991-07-09 1993-06-15 The Pilot Ink Co., Ltd. Thermochromic laminate member and toy utilizing the same
JP3232602B2 (en) 1991-09-06 2001-11-26 ソニー株式会社 Euclidean circuit
US5273429A (en) 1992-04-03 1993-12-28 Foster-Miller, Inc. Method and apparatus for modeling a dental prosthesis
FR2693096B1 (en) 1992-07-06 1994-09-23 Deshayes Marie Josephe Process for modeling the cranial and facial morphology from an x-ray of the skull.
US5542842A (en) 1992-11-09 1996-08-06 Ormco Corporation Bracket placement jig assembly and method of placing orthodontic brackets on teeth therewith
US5456600A (en) 1992-11-09 1995-10-10 Ormco Corporation Coordinated orthodontic archwires and method of making same
US5575654A (en) 1992-11-24 1996-11-19 Fontenot; Mark G. Apparatus and method for lightening teeth
US5528735A (en) 1993-03-23 1996-06-18 Silicon Graphics Inc. Method and apparatus for displaying data within a three-dimensional information landscape
SE501410C2 (en) 1993-07-12 1995-02-06 Nobelpharma Ab Method and apparatus in connection with the manufacture of tooth, bridge, etc.
CN1054737C (en) 1993-07-12 2000-07-26 欧索-泰公司 A multi-racial preformed orthodontic treatment appliance
SE501411C2 (en) 1993-07-12 1995-02-06 Nobelpharma Ab Method and apparatus for three-dimensional body useful in the human body
US5382164A (en) 1993-07-27 1995-01-17 Stern; Sylvan S. Method for making dental restorations and the dental restoration made thereby
US5338198A (en) 1993-11-22 1994-08-16 Dacim Laboratory Inc. Dental modeling simulator
SE502427C2 (en) 1994-02-18 1995-10-16 Nobelpharma Ab Method and device utilizing articulator and computer equipment
US5584688A (en) 1994-03-22 1996-12-17 Sangi Co., Ltd. Medicine injection device
US5665332A (en) 1994-03-28 1997-09-09 Oralcare Systems, Inc. System for delivering foams containing medicaments
US5880961A (en) 1994-08-02 1999-03-09 Crump; Craig D. Appararus and method for creating three-dimensional modeling data from an object
WO1996025121A1 (en) * 1995-02-17 1996-08-22 Trisa Bürstenfabrik Ag Triengen Oral douche with a stirrup-shaped nozzle holder
US5549476A (en) 1995-03-27 1996-08-27 Stern; Sylvan S. Method for making dental restorations and the dental restoration made thereby
JP3672966B2 (en) 1995-04-14 2005-07-20 株式会社ユニスン Method and apparatus for creating dental prediction model
US5924863A (en) 1995-04-18 1999-07-20 Jacobs; Allison J. Delivery system
US5645421A (en) 1995-04-28 1997-07-08 Great Lakes Orthodontics Ltd. Orthodontic appliance debonder
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
FI955389A0 (en) 1995-11-09 1995-11-09 Antti Sakari Aaltonen Prophylactic prophylactic preparations and administration of breast cancer pathogens
ATE237285T1 (en) * 1995-12-18 2003-05-15 Jens Schug MEDICAL IMPLANT
US5725376A (en) 1996-02-27 1998-03-10 Poirier; Michel Methods for manufacturing a dental implant drill guide and a dental implant superstructure
US5692894A (en) 1996-04-08 1997-12-02 Raintree Essix, Inc. Thermoformed plastic dental retainer and method of construction
US5725378A (en) 1996-08-16 1998-03-10 Wang; Hong-Chi Artificial tooth assembly
AU4239597A (en) * 1996-08-29 1998-03-19 Advanced Research And Technology Institute, Inc. Novel pharmacotherapeutic process and composition for central nervous system disorders
JPH1075963A (en) 1996-09-06 1998-03-24 Nikon Corp Method for designing dental prosthetic appliance model and medium recording program for executing the method
JP2824424B2 (en) 1996-11-07 1998-11-11 株式会社エフ・エーラボ 3D machining method
US6217334B1 (en) 1997-01-28 2001-04-17 Iris Development Corporation Dental scanning method and apparatus
US5957686A (en) 1997-04-29 1999-09-28 Anthony; Wayne L. Incisor block
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US5879158A (en) 1997-05-20 1999-03-09 Doyle; Walter A. Orthodontic bracketing system and method therefor
US5866058A (en) 1997-05-29 1999-02-02 Stratasys Inc. Method for rapid prototyping of solid models
US6306370B1 (en) 1997-05-30 2001-10-23 Ultradent Products, Inc. Compositions and methods for whitening and desensitizing teeth
US5975893A (en) 1997-06-20 1999-11-02 Align Technology, Inc. Method and system for incrementally moving teeth
US6183248B1 (en) 1998-11-30 2001-02-06 Muhammad Chishti System and method for releasing tooth positioning appliances
US6146655A (en) 1997-08-29 2000-11-14 Softy-Flex Inc. Flexible intra-oral bandage and drug delivery system
US6293790B1 (en) 1998-02-18 2001-09-25 J. Keith Hilliard Heated orthodontic pliers
BE1011899A6 (en) 1998-04-30 2000-02-01 Ucb Sa PHARMACEUTICAL USE gelling.
US5971754A (en) 1998-07-30 1999-10-26 Sondhi; Anoop Indirect bonding method and adhesive for orthodontic treatment
US5964587A (en) 1998-09-16 1999-10-12 Sato; Mikio Bite control point and a method to form a projection on tooth surface
US6123544A (en) 1998-12-18 2000-09-26 3M Innovative Properties Company Method and apparatus for precise bond placement of orthodontic appliances
US6142780A (en) 1999-02-01 2000-11-07 3M Innovative Properties Company Custom tray for delivering medication to oral structures
US6068475A (en) 1999-02-11 2000-05-30 Stoyka, Jr.; Frank S. Flavored and medicated therapeutic mouthpiece
WO2000047203A1 (en) 1999-02-12 2000-08-17 Mqs, Inc. Formulation and system for intra-oral delivery of pharmaceutical agents
US6089869A (en) 1999-03-15 2000-07-18 Schwartz; Dann A. Low-density polyethylene dental bleaching trays
US6190165B1 (en) 1999-03-23 2001-02-20 Ormco Corporation Plastic orthodontic appliance having mechanical bonding base and method of making same
CA2375914A1 (en) 1999-06-04 2000-12-14 Delrx Pharmaceutical Corporation Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
US6328715B1 (en) * 1999-09-21 2001-12-11 William B. Dragan Unit dose low viscosity material dispensing system
US20050175959A1 (en) * 2000-03-14 2005-08-11 Coll Partners Ltd. System for the controlled delivery of an active material to a dental site
US6485273B1 (en) 2000-09-01 2002-11-26 Mcnc Distributed MEMS electrostatic pumping devices
US7553157B2 (en) 2004-09-24 2009-06-30 Align Technology, Inc. Systems and methods for dental appliance compliance indication
EP1318761B1 (en) * 2000-09-21 2011-01-19 Align Technology, Inc. System for concurrent tooth repositioning and substance delivery
US6966773B2 (en) * 2000-11-13 2005-11-22 Keller Duane C Periodontal medicament delivery tray
US6814085B2 (en) 2000-12-29 2004-11-09 Steven J. Brattesani Dental floss with usage identification capability
US6638219B1 (en) 2001-01-11 2003-10-28 Asch-Klaassen Sonics, Inc. Method of mapping internal 3-D structure of dental formations
US6623698B2 (en) 2001-03-12 2003-09-23 Youti Kuo Saliva-monitoring biosensor electrical toothbrush
CN1571654A (en) * 2001-08-17 2005-01-26 史密丝克莱恩比彻姆有限公司 Oral care substance delivery strip
US6491037B1 (en) 2001-10-10 2002-12-10 Daniel J. Mortenson Temperature indicating mouth guard
US6638241B2 (en) 2002-01-03 2003-10-28 Israel Yerushalmy Apparatus for treating bruxism
US6682348B2 (en) 2002-03-29 2004-01-27 Orapharma, Inc. Dispensing apparatus and cartridge
US20040158194A1 (en) 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
US20040260234A1 (en) 2003-04-21 2004-12-23 Ravi Srinivasan Apparatus and methods for repetitive microjet durg delivery priority statement
US8346482B2 (en) 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
US6997708B2 (en) * 2003-10-22 2006-02-14 Ultradent Products, Inc. Treatment compositions and strips having a solid adhesive layer and treatment gel adjacent thereto
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7766658B2 (en) 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215706A (en) * 1978-10-13 1980-08-05 Loew's Theatres, Inc. Nicotine transfer process
US4892736A (en) * 1983-10-07 1990-01-09 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US5904718A (en) * 1986-03-27 1999-05-18 Biocoll Laboratories, Inc. Delayed drug delivery system
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4846165A (en) * 1986-11-26 1989-07-11 Dentsply Research & Development Corp. Wound dressing membrane
US4834110A (en) * 1988-02-01 1989-05-30 Richard Patricia A Suction clamped treatment cup saliva sampler
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5330746A (en) * 1988-05-03 1994-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental varnish composition, and method of use
US5639795A (en) * 1988-05-03 1997-06-17 Perio Products, Ltd. Liquid polymer composition, and method of use
US5438076A (en) * 1988-05-03 1995-08-01 Perio Products, Ltd. Liquid polymer composition, and method of use
US5648399A (en) * 1988-05-03 1997-07-15 Perio Products, Ltd. Liquid polymer composition and method of use
US4861268A (en) * 1988-06-13 1989-08-29 Transpharm Group Tooth-anchored beneficial agent delivery device
US5194003A (en) * 1988-06-13 1993-03-16 Transpharm Group, Inc. Removable device for delivering beneficial agents orally
US6093084A (en) * 1988-08-01 2000-07-25 Dentsply Research & Development Corp. Device and method for dispensing polymerizable compositions
US4990089A (en) * 1988-08-23 1991-02-05 Dunhall Pharmaceuticals, Inc. Method and material for brightening teeth
US5098711A (en) * 1988-11-14 1992-03-24 Ira Hill Method of treating the oral cavity with dental floss containing chemotherapeutic agents
US5403577A (en) * 1989-01-31 1995-04-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental composition for hypersensitive teeth
US5139768A (en) * 1989-01-31 1992-08-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental composition for hypersensitive teeth
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
US5098363A (en) * 1989-12-11 1992-03-24 Pressware International, Inc. Precise positioning of blank in die
US5855870A (en) * 1990-03-22 1999-01-05 Ultradent Products, Inc. Method for treating sensitive teeth
US5770182A (en) * 1990-03-22 1998-06-23 Ultradent Products, Inc. Methods for treating teeth with anticariogenic and antimicrobial dental compositions
US6036943A (en) * 1990-03-22 2000-03-14 Ultradent Products, Inc. Methods for treating a person's teeth using sticky dental compositions in combination with passive-type dental trays
US6086855A (en) * 1990-03-22 2000-07-11 Ultradent Products, Inc. Methods for making scalloped dental trays for use in treating teeth with sticky dental compositions
US6183251B1 (en) * 1990-03-22 2001-02-06 Ultradent Products, Inc. Scalloped dental trays for use in treating teeth with sticky dental compositions
US5234342A (en) * 1990-03-22 1993-08-10 Ultradent Products, Inc. Sustained release method for treating teeth surfaces
US5770105A (en) * 1990-03-22 1998-06-23 Ultradent Products, Inc. Methods for manufacturing sticky bleaching compositions
US5759038A (en) * 1990-03-22 1998-06-02 Fischer; Dan E. Dental kit for applying sticky dental bleaching compositions to a person's teeth
US5409631A (en) * 1990-03-22 1995-04-25 Ultradent Products Dental bleaching compositions and methods for bleaching teeth surfaces
US5725843A (en) * 1990-03-22 1998-03-10 Ultradent Products, Inc. Methods for bleaching teeth surfaces
US5759037A (en) * 1990-03-22 1998-06-02 Ultradent Products Inc Methods for manufacturing dental trays having thin walls for increased comfort
US5240415A (en) * 1990-06-07 1993-08-31 Haynie Michel B Dental bleach system having separately compartmented fumed silica and hydrogen peroxide and method of using
US5080583A (en) * 1990-11-23 1992-01-14 Hunting Tanya L Fragranced orthodontic appliance and method of making
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5433952A (en) * 1992-05-04 1995-07-18 Digestive Care Inc. Intraoral medicament-releasing device
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
US6616444B2 (en) * 1992-11-09 2003-09-09 Ormco Corporation Custom orthodontic appliance forming method and apparatus
US5945404A (en) * 1993-09-29 1999-08-31 Nissin Shokuhin Kabushiki Kaisha 21-Substituted steroid compound
US5745598A (en) * 1994-03-11 1998-04-28 Shaw; Venson Ming Heng Statistics based segmentation and parameterization method for dynamic processing, identification, and verification of binary contour image
US6060500A (en) * 1994-05-09 2000-05-09 Board Of Regents, The University Of Texas System Suppression, by 5-lipoxygenase inhibitors, of bone resorption
US6455541B1 (en) * 1994-05-09 2002-09-24 Board Of Regents, The University Of Texas System Suppression, by 5-lipoxygenase inhibitors, of bone resorption
US5534524A (en) * 1994-05-09 1996-07-09 Board Of Regents, The University Of Texas System Suppression of bone resorption by quinolines
US5711935A (en) * 1994-05-10 1998-01-27 Whitehill Oral Technologies, Inc. Dental floss
US5513630A (en) * 1995-03-08 1996-05-07 Century; Theodore J. Powder dispenser
US5542412A (en) * 1995-03-08 1996-08-06 Century; Theodore J. Powder Dispenser
US5866432A (en) * 1995-04-12 1999-02-02 Oy Medix Biochemica Ab Methods for diagnosis of periodontal diseases
US6573282B1 (en) * 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6206920B1 (en) * 1996-05-13 2001-03-27 Ben-Gurion University Of The Negev Composition and method for forming biodegradable implants in situ and uses of these implants
US5861298A (en) * 1996-06-17 1999-01-19 Smithkline Beecham Corporation Cathepsin K gene
US6021352A (en) * 1996-06-26 2000-02-01 Medtronic, Inc, Diagnostic testing methods and apparatus for implantable therapy devices
US6132384A (en) * 1996-06-26 2000-10-17 Medtronic, Inc. Sensor, method of sensor implant and system for treatment of respiratory disorders
US5895360A (en) * 1996-06-26 1999-04-20 Medtronic, Inc. Gain control for a periodic signal and method regarding same
US5944680A (en) * 1996-06-26 1999-08-31 Medtronic, Inc. Respiratory effort detection method and apparatus
US6099479A (en) * 1996-06-26 2000-08-08 Medtronic, Inc. Method and apparatus for operating therapy system
US5954869A (en) * 1997-05-07 1999-09-21 Bioshield Technologies, Inc. Water-stabilized organosilane compounds and methods for using the same
US6120587A (en) * 1997-05-07 2000-09-19 Bioshield Technologies, Inc. Water-stabilized organosilane compounds and methods for using the same
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6562363B1 (en) * 1997-09-26 2003-05-13 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6109916A (en) * 1997-10-03 2000-08-29 Wilcko; M. Thomas Orthodontic method and device
US6074674A (en) * 1997-10-31 2000-06-13 University Of Kentucky Research Foundation Formulations for sustained-release of topical anesthetics and methods of making and using same
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
US6372543B1 (en) * 1997-12-19 2002-04-16 Stmicroelectronics, Inc. Wrap-around interconnect for fine pitch ball grid array
US6072100A (en) * 1998-01-28 2000-06-06 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US6720009B2 (en) * 1998-02-27 2004-04-13 Biora Bioex Ab Matrix protein compositions for treating infection
US6503539B2 (en) * 1998-02-27 2003-01-07 Biora Bioex Ab Matrix protein compositions for wound healing
US6729878B2 (en) * 1998-04-03 2004-05-04 Morton Cohen Composition and method for improving, altering, and treating teeth
US6036494A (en) * 1998-04-03 2000-03-14 Cohen; Morton Method for cosmetically improving and altering the appearance of teeth
US6210163B1 (en) * 1998-04-03 2001-04-03 Morton Cohen Composition and method for cosmetically improving and altering the appearance of teeth
US5865332A (en) * 1998-04-27 1999-02-02 Northern Telecom Limited Environmental protection housing
US6589050B1 (en) * 1998-10-21 2003-07-08 Paul W. Mackey Fragranced orthodontic appliances and method of forming same
US6368576B1 (en) * 1998-11-12 2002-04-09 Ultradent Products, Inc. Methods for bleaching, opacifying and desensitizing teeth
US6287120B1 (en) * 1998-12-04 2001-09-11 Peter E. Wiesel Methods and apparatus for treating teeth
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
US6503955B1 (en) * 1999-09-11 2003-01-07 The Procter & Gamble Company Pourable liquid vehicles
US6699384B1 (en) * 1999-09-21 2004-03-02 Battelle Memorial Institute Compact electrochemical sensor system and method for field testing for metals in saliva or other fluids
US6267590B1 (en) * 1999-11-24 2001-07-31 Agion Technologies, Llc Antimicrobial dental products
US20020004065A1 (en) * 2000-01-20 2002-01-10 David Kanios Compositions and methods to effect the release profile in the transdermal administration of active agents
US6772026B2 (en) * 2000-04-05 2004-08-03 Therics, Inc. System and method for rapidly customizing design, manufacture and/or selection of biomedical devices
US6509028B2 (en) * 2000-06-26 2003-01-21 Epicept Corporation Methods and compositions for treating pain of the mucous membrane
US6607382B1 (en) * 2000-09-21 2003-08-19 Align Technology, Inc. Methods and systems for concurrent tooth repositioning and substance delivery
US20040101801A1 (en) * 2000-09-22 2004-05-27 Mao Jeremy Jian Use of cyclic forces to expedite remodeling of craniofacial bones
US6528555B1 (en) * 2000-10-12 2003-03-04 3M Innovative Properties Company Adhesive for use in the oral environment having color-changing capabilities
US6607387B2 (en) * 2000-10-30 2003-08-19 Healthetech, Inc. Sensor system for diagnosing dental conditions
US6736980B2 (en) * 2000-11-22 2004-05-18 Pti Technologies, Inc. Prognostic health monitoring of fluidic systems using MEMS technology
US6692771B2 (en) * 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
US20030003421A1 (en) * 2001-07-02 2003-01-02 Thierry Bestenheider Pre-impregnated disposable dental substance delivery mouthpiece
US20050095561A1 (en) * 2002-05-03 2005-05-05 Reinhard Schatzner Device for applying dental treatment agent to teeth and/or gums
US20040023853A1 (en) * 2002-05-23 2004-02-05 Peri Krishna G. Antagonistic peptides of prostaglandin E2 receptor subtype EP4
US6916463B2 (en) * 2002-09-24 2005-07-12 The Procter & Gamble Company Oral products having an aesthetic layer
US20040115587A1 (en) * 2002-11-01 2004-06-17 Bas Medical, Inc. Methods and systems for enabling and stabilizing tooth movement
US6984128B2 (en) * 2002-11-01 2006-01-10 Bas Medical, Inc. Methods for enabling and stabilizing tooth movement
US20040115137A1 (en) * 2002-12-17 2004-06-17 Verrall Andrew P. Water-soluble film for oral administration
US20050119723A1 (en) * 2003-11-28 2005-06-02 Medlogics Device Corporation Medical device with porous surface containing bioerodable bioactive composites and related methods
US20050152850A1 (en) * 2004-01-09 2005-07-14 Engebretson Steven P. Methods and compositions for facilitating metabolic control
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance

Cited By (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11026768B2 (en) 1998-10-08 2021-06-08 Align Technology, Inc. Dental appliance reinforcement
US11589954B2 (en) 2004-02-24 2023-02-28 Align Technology, Inc. Method and system for designing and producing dental prosthesis and appliances
US10413385B2 (en) 2004-02-27 2019-09-17 Align Technology, Inc. Method and system for providing dynamic orthodontic assessment and treatment profiles
US10154889B2 (en) 2004-09-24 2018-12-18 Align Technology, Inc. Release agent receptacle
US11559374B2 (en) 2004-09-24 2023-01-24 Align Technology, Inc. Release agent receptacle
US8075309B2 (en) 2004-11-30 2011-12-13 Align Technology, Inc. Systems and methods for intra-oral drug delivery
US8439674B2 (en) 2004-11-30 2013-05-14 Align Technology, Inc. Systems and methods for intra-oral drug delivery
US9308326B2 (en) 2005-02-11 2016-04-12 Massachusetts Institute Of Technology Controlled needle-free transport
US10326347B2 (en) 2005-02-11 2019-06-18 Massachusetts Institute Of Technology Controlled needle-free transport
US20100068670A1 (en) * 2006-03-28 2010-03-18 Panasonic Electric Works Co., Ltd. Orthodontic appliance
US20090061379A1 (en) * 2006-03-28 2009-03-05 Matsushita Electric Works, Ltd. Orthodontic Appliance
US8133054B2 (en) 2006-03-28 2012-03-13 Panasonic Electric Works Co., Ltd. Method for producing an orthodontic appliance having a vibrating element
US8152521B2 (en) 2006-03-28 2012-04-10 Panasonic Corporation Orthodontic appliance
US20090239188A1 (en) * 2006-06-06 2009-09-24 Reika Ortho Technologies, Inc. Changzhou Hi-Tech District Multiple Dime Transduction orthodontic devices
WO2008074153A1 (en) 2006-12-18 2008-06-26 Electronic Dietary Foods Inc. Device for delivery of a substance
US8795721B2 (en) 2006-12-18 2014-08-05 Eatlittle Inc. Device for delivery of a substance
US11806206B2 (en) 2007-03-14 2023-11-07 Dentsply Sirona Inc. System and method for correcting malocclusion
US10806545B2 (en) 2007-03-14 2020-10-20 Advanced Orthodontics And Education Assiocation, Llc System and method for correcting malocclusion
US10500019B2 (en) 2007-03-14 2019-12-10 Orthoaccel Technologies, Inc. System and method for correcting malocclusion
US20100055634A1 (en) * 2007-03-14 2010-03-04 Orthoaccel Technologies, Inc. Vibrating dental devices
US9028250B2 (en) 2007-03-14 2015-05-12 Orthoaccel Technologies, Inc. Vibrating dental devices
US9668828B2 (en) 2007-03-14 2017-06-06 Orthoaccel Technologies, Inc. Systems, methods, and adjunctive procedures for correcting malocclusion
CN102755201A (en) * 2007-05-03 2012-10-31 矫正技术公司 Dental appliance wear indication and release agent receptacle
US9730769B2 (en) 2007-05-03 2017-08-15 Align Technology, Inc. Release agent receptacle
US11717384B2 (en) 2007-05-25 2023-08-08 Align Technology, Inc. Dental appliance with eruption tabs
US20110165533A1 (en) * 2007-06-01 2011-07-07 Align Technology, Inc. Method and system for providing alternating use orthodontic aligners
WO2008146117A1 (en) * 2007-06-01 2008-12-04 Align Technology, Inc. Method and system for providing alternating use orthodontic aligners
US11514199B2 (en) 2007-10-12 2022-11-29 Align Technology, Inc. Prosthodontic and orthodontic apparatus and methods
US11436191B2 (en) 2007-11-08 2022-09-06 Align Technology, Inc. Systems and methods for anonymizing patent images in relation to a clinical data file
US20090184095A1 (en) * 2008-01-23 2009-07-23 Hoya Corporation Method of Connecting Pipe Members for Endoscope
US11213368B2 (en) 2008-03-25 2022-01-04 Align Technology, Inc. Reconstruction of non-visible part of tooth
US20110136070A1 (en) * 2008-03-31 2011-06-09 Orthoaccel Technologies,Inc. Vibrating compressible dental plate for correcting malocclusion
US10543064B2 (en) 2008-05-23 2020-01-28 Align Technology, Inc. Dental implant positioning
US11417432B2 (en) 2008-05-23 2022-08-16 Align Technology, Inc. Smile designer
US10758321B2 (en) 2008-05-23 2020-09-01 Align Technology, Inc. Smile designer
US11232867B2 (en) 2008-05-23 2022-01-25 Align Technology, Inc. Smile designer
US9084657B2 (en) 2008-06-12 2015-07-21 Align Technology, Inc. Dental appliance
US10842601B2 (en) 2008-06-12 2020-11-24 Align Technology, Inc. Dental appliance
US8523565B2 (en) * 2008-06-12 2013-09-03 Align Technology, Inc. Dental appliance
US20120219922A1 (en) * 2008-06-12 2012-08-30 Align Technology, Inc. Dental appliance
US11654004B2 (en) 2008-07-17 2023-05-23 Align Technology, Inc. Methods, systems and accessories useful for procedures relating to dental implants
US11471252B2 (en) 2008-10-08 2022-10-18 Align Technology, Inc. Dental positioning appliance having mesh portion
US11083545B2 (en) 2009-03-19 2021-08-10 Align Technology, Inc. Dental wire attachment
US10919209B2 (en) 2009-08-13 2021-02-16 Align Technology, Inc. Method of forming a dental appliance
US10463276B2 (en) 2009-09-01 2019-11-05 Massachusetts Institute Of Technology Nonlinear system identification techniques and devices for discovering dynamic and static tissue properties
US9517030B2 (en) 2009-09-01 2016-12-13 Massachusetts Institute Of Technology Nonlinear system identification techniques and devices for discovering dynamic and static tissue properties
US20120003601A1 (en) * 2009-12-15 2012-01-05 Massachusetts Institute Of Technology Jet Injector Use In Oral Evaluation
US9333060B2 (en) 2009-12-15 2016-05-10 Massachusetts Institute Of Technology Plaque removal and differentiation of tooth and gum
US11471250B2 (en) 2010-04-30 2022-10-18 Align Technology, Inc. Reinforced aligner hooks
US10524881B2 (en) 2010-04-30 2020-01-07 Align Technology, Inc. Patterned dental positioning appliance
US11612454B2 (en) 2010-04-30 2023-03-28 Align Technology, Inc. Individualized orthodontic treatment index
US11534861B2 (en) 2011-09-21 2022-12-27 Align Technology, Inc. Laser cutting
US10421152B2 (en) 2011-09-21 2019-09-24 Align Technology, Inc. Laser cutting
US10828719B2 (en) 2011-09-21 2020-11-10 Align Technology, Inc. Laser cutting
US11426259B2 (en) 2012-02-02 2022-08-30 Align Technology, Inc. Identifying forces on a tooth
US10893918B2 (en) 2012-03-01 2021-01-19 Align Technology, Inc. Determining a dental treatment difficulty
US9968421B2 (en) * 2012-03-26 2018-05-15 Orthoaccel Technologies, Inc. Tooth positioner and vibrator combination
US20130252193A1 (en) * 2012-03-26 2013-09-26 Orthoaccel Technologies, Inc. Tooth positioner and vibrator combination
US11648090B2 (en) 2012-05-14 2023-05-16 Align Technology, Inc. Multilayer polymer sheets
US10610332B2 (en) 2012-05-22 2020-04-07 Align Technology, Inc. Adjustment of tooth position in a virtual dental model
US20140178830A1 (en) * 2012-12-21 2014-06-26 Friedrich Widu Guidance element for a tooth
US10004573B2 (en) * 2012-12-21 2018-06-26 Friedrich Widu Guidance element for a tooth
US10918701B2 (en) 2014-03-20 2021-02-16 Technion Research & Development Foundation Limited Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof
US10183064B2 (en) 2014-03-20 2019-01-22 Technion Research & Development Foundation Limited Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof
US11744678B2 (en) 2014-08-22 2023-09-05 Align Technology, Inc. Attachment structure
US11744677B2 (en) 2014-09-19 2023-09-05 Align Technology, Inc. Arch adjustment appliance
US11638629B2 (en) 2014-09-19 2023-05-02 Align Technology, Inc. Arch expanding appliance
US10537405B2 (en) 2014-11-13 2020-01-21 Align Technology, Inc. Dental appliance with cavity for an unerupted or erupting tooth
US11752030B2 (en) 2015-01-13 2023-09-12 Align Technology, Inc. Systems and methods for positioning a patient's mandible in response to sleep apnea status
US11793667B2 (en) 2015-01-13 2023-10-24 Align Technology, Inc. Systems, methods, and devices for applying distributed forces for mandibular advancement
US11771531B2 (en) 2015-01-13 2023-10-03 Align Technology, Inc. Mandibular advancement and retraction via bone anchoring devices
US10504386B2 (en) 2015-01-27 2019-12-10 Align Technology, Inc. Training method and system for oral-cavity-imaging-and-modeling equipment
US11419710B2 (en) * 2015-07-07 2022-08-23 Align Technology, Inc. Systems, apparatuses and methods for substance delivery from dental appliance
US10201409B2 (en) 2015-07-07 2019-02-12 Align Technology, Inc. Dental appliance having ornamental design
US20170007386A1 (en) * 2015-07-07 2017-01-12 Align Technology, Inc. Systems, apparatuses and methods for substance delivery from dental appliance
US20230018058A1 (en) * 2015-07-07 2023-01-19 Align Technology, Inc. Appliances for intraoral delivery of agents
US11553989B2 (en) 2015-10-07 2023-01-17 uLab Systems, Inc. Tooth modeling system
US11051913B2 (en) 2015-10-07 2021-07-06 Ulab Systems Inc. Methods for fabricating dental appliances or shells
US11583365B2 (en) 2015-10-07 2023-02-21 uLab Systems, Inc. System and methods for tooth movement as a flock
US10335250B2 (en) 2015-10-07 2019-07-02 uLab Systems, Inc. Three-dimensional printed dental appliances using lattices
US11771524B2 (en) 2015-10-07 2023-10-03 uLab Systems, Inc. Three-dimensional printed dental appliances using support structures
US11833006B2 (en) 2015-10-07 2023-12-05 uLab Systems, Inc. Systems and methods for fabricating dental appliances or shells
US10548690B2 (en) 2015-10-07 2020-02-04 uLab Systems, Inc. Orthodontic planning systems
US10624717B2 (en) 2015-10-07 2020-04-21 Ulab Systems Inc. Tooth modeling system
US10631953B2 (en) 2015-10-07 2020-04-28 uLab Systems, Inc. Three-dimensional printed dental appliances using support structures
US10357336B2 (en) 2015-10-07 2019-07-23 uLab Systems, Inc. Systems and methods for fabricating dental appliances or shells
US10881486B2 (en) 2015-10-07 2021-01-05 uLab Systems, Inc. Three-dimensional printed dental appliances using lattices
US11638628B2 (en) 2015-10-07 2023-05-02 Ulab Systems Inc. Three-dimensional printed dental appliances using lattices
US11554000B2 (en) 2015-11-12 2023-01-17 Align Technology, Inc. Dental attachment formation structure
US11931222B2 (en) 2015-11-12 2024-03-19 Align Technology, Inc. Dental attachment formation structures
US11103330B2 (en) 2015-12-09 2021-08-31 Align Technology, Inc. Dental attachment placement structure
US11596502B2 (en) 2015-12-09 2023-03-07 Align Technology, Inc. Dental attachment placement structure
US11178867B2 (en) 2016-02-25 2021-11-23 Nobio Ltd. Micro and nanoparticulate compositions comprising anti-microbially active groups
US10470847B2 (en) 2016-06-17 2019-11-12 Align Technology, Inc. Intraoral appliances with sensing
US11612455B2 (en) 2016-06-17 2023-03-28 Align Technology, Inc. Orthodontic appliance performance monitor
US11304778B2 (en) 2016-06-17 2022-04-19 Align Technology, Inc. Intraoral appliances with proximity and contact sensing
US10509838B2 (en) 2016-07-27 2019-12-17 Align Technology, Inc. Methods and apparatuses for forming a three-dimensional volumetric model of a subject's teeth
US10585958B2 (en) 2016-07-27 2020-03-10 Align Technology, Inc. Intraoral scanner with dental diagnostics capabilities
US10606911B2 (en) 2016-07-27 2020-03-31 Align Technology, Inc. Intraoral scanner with dental diagnostics capabilities
US10588723B2 (en) 2016-09-21 2020-03-17 uLab Systems, Inc. Digital dental examination and documentation
US10952821B2 (en) 2016-09-21 2021-03-23 uLab Systems, Inc. Combined orthodontic movement of teeth with temporomandibular joint therapy
US11707180B2 (en) 2016-09-21 2023-07-25 uLab Systems, Inc. Digital dental examination and documentation
US10357342B2 (en) 2016-09-21 2019-07-23 uLab Systems, Inc. Digital dental examination and documentation
US10925698B2 (en) 2016-09-21 2021-02-23 uLab Systems, Inc. Digital dental examination and documentation
US11364098B2 (en) 2016-09-21 2022-06-21 uLab Systems, Inc. Combined orthodontic movement of teeth with airway development therapy
US10595966B2 (en) 2016-11-04 2020-03-24 Align Technology, Inc. Methods and apparatuses for dental images
US11026831B2 (en) 2016-12-02 2021-06-08 Align Technology, Inc. Dental appliance features for speech enhancement
US11376101B2 (en) 2016-12-02 2022-07-05 Align Technology, Inc. Force control, stop mechanism, regulating structure of removable arch adjustment appliance
US10993783B2 (en) 2016-12-02 2021-05-04 Align Technology, Inc. Methods and apparatuses for customizing a rapid palatal expander
US11273011B2 (en) 2016-12-02 2022-03-15 Align Technology, Inc. Palatal expanders and methods of expanding a palate
US10548700B2 (en) 2016-12-16 2020-02-04 Align Technology, Inc. Dental appliance etch template
US9968777B1 (en) * 2016-12-27 2018-05-15 Colgate-Palmolive Company Power harvesting oral device
US11717678B2 (en) 2016-12-27 2023-08-08 Colgate-Palmolive Company Oral care device
US10874855B2 (en) 2016-12-27 2020-12-29 Colgate-Palmolive Company Power harvesting oral device
US10779718B2 (en) 2017-02-13 2020-09-22 Align Technology, Inc. Cheek retractor and mobile device holder
US10613515B2 (en) 2017-03-31 2020-04-07 Align Technology, Inc. Orthodontic appliances including at least partially un-erupted teeth and method of forming them
US11194312B2 (en) 2017-03-31 2021-12-07 Align Technology, Inc. Orthodontic appliances including at least partially un-erupted teeth and method of forming them
US11045283B2 (en) 2017-06-09 2021-06-29 Align Technology, Inc. Palatal expander with skeletal anchorage devices
US10639134B2 (en) 2017-06-26 2020-05-05 Align Technology, Inc. Biosensor performance indicator for intraoral appliances
US11576766B2 (en) 2017-06-26 2023-02-14 Align Technology, Inc. Biosensor performance indicator for intraoral appliances
US10885521B2 (en) 2017-07-17 2021-01-05 Align Technology, Inc. Method and apparatuses for interactive ordering of dental aligners
US11419702B2 (en) 2017-07-21 2022-08-23 Align Technology, Inc. Palatal contour anchorage
US10517482B2 (en) 2017-07-27 2019-12-31 Align Technology, Inc. Optical coherence tomography for orthodontic aligners
US11633268B2 (en) 2017-07-27 2023-04-25 Align Technology, Inc. Tooth shading, transparency and glazing
US11116605B2 (en) 2017-08-15 2021-09-14 Align Technology, Inc. Buccal corridor assessment and computation
US11123156B2 (en) 2017-08-17 2021-09-21 Align Technology, Inc. Dental appliance compliance monitoring
US11134676B2 (en) 2017-08-30 2021-10-05 Nobio Ltd. Anti-microbial particles and methods of use thereof
US11883256B2 (en) 2017-10-05 2024-01-30 Align Technology, Inc. Methods of forming interproximal reduction templates
US10813720B2 (en) 2017-10-05 2020-10-27 Align Technology, Inc. Interproximal reduction templates
US11534268B2 (en) 2017-10-27 2022-12-27 Align Technology, Inc. Alternative bite adjustment structures
US11576752B2 (en) 2017-10-31 2023-02-14 Align Technology, Inc. Dental appliance having selective occlusal loading and controlled intercuspation
US11793608B2 (en) 2017-11-01 2023-10-24 Align Technology, Inc. Systems and methods for correcting malocclusions of teeth
US11096763B2 (en) 2017-11-01 2021-08-24 Align Technology, Inc. Automatic treatment planning
US11534974B2 (en) 2017-11-17 2022-12-27 Align Technology, Inc. Customized fabrication of orthodontic retainers based on patient anatomy
US11219506B2 (en) 2017-11-30 2022-01-11 Align Technology, Inc. Sensors for monitoring oral appliances
US11432908B2 (en) 2017-12-15 2022-09-06 Align Technology, Inc. Closed loop adaptive orthodontic treatment methods and apparatuses
US10980613B2 (en) 2017-12-29 2021-04-20 Align Technology, Inc. Augmented reality enhancements for dental practitioners
US11589956B2 (en) 2018-01-26 2023-02-28 Align Technology, Inc. Visual prosthetic and orthodontic treatment planning
US11013581B2 (en) 2018-01-26 2021-05-25 Align Technology, Inc. Diagnostic intraoral methods and apparatuses
US10390913B2 (en) 2018-01-26 2019-08-27 Align Technology, Inc. Diagnostic intraoral scanning
US10813727B2 (en) 2018-01-26 2020-10-27 Align Technology, Inc. Diagnostic intraoral tracking
WO2019183299A1 (en) * 2018-03-21 2019-09-26 Silverman Joshua T Edentulous specific support and aesthetic restorative appliance
US11510767B2 (en) 2018-03-21 2022-11-29 Joshua T. Silverman Edentulous specific support and aesthetic restorative appliance
US11564777B2 (en) 2018-04-11 2023-01-31 Align Technology, Inc. Releasable palatal expanders
US11504214B2 (en) 2018-05-11 2022-11-22 Align Technology, Inc. Devices, systems, and computer-implemented methods for dental attachment templates
US11701203B2 (en) 2018-06-29 2023-07-18 Align Technology, Inc. Dental appliance hook placement and visualization
US11718019B2 (en) 2018-09-14 2023-08-08 Align Technology, Inc. System for hybrid 3D printing with photo-curable materials
CN112739288A (en) * 2018-09-24 2021-04-30 3M创新有限公司 Dental appliance with cosmetic therapeutic aqueous solution
US11642199B2 (en) 2018-09-24 2023-05-09 3M Innovative Properties Company Dental appliance with cosmetic therapeutic aqueous solution
US20210353387A1 (en) * 2018-10-18 2021-11-18 3M Innovative Properties Company Dental appliance with structured surface
CN109394364A (en) * 2018-10-29 2019-03-01 山东迈尔医疗科技有限公司 A kind of manufacture craft of novel 3D printing removable denture bracket
US11771527B2 (en) 2019-02-20 2023-10-03 Sdc U.S. Smilepay Spv Limited wear aligner and treatment methods
US11602414B2 (en) 2019-06-11 2023-03-14 Align Technology, Inc. Aligner material, cleanliness, and quality detection via aligner case
US11471253B2 (en) 2019-09-16 2022-10-18 Align Technology, Inc. Durable ornamental indicia carrier
US11109946B2 (en) 2019-09-16 2021-09-07 Align Technology, Inc. Durable ornamental indicia carrier
US11786341B2 (en) 2019-12-09 2023-10-17 Align Technology, Inc. Occlusal block design for lateral locking
US11801124B2 (en) 2019-12-09 2023-10-31 Align Technology, Inc. Occlusal blocks for mandibular relocation
US11723748B2 (en) 2019-12-23 2023-08-15 Align Technology, Inc. 2D-to-3D tooth reconstruction, optimization, and positioning frameworks using a differentiable renderer
WO2021161123A1 (en) * 2020-02-12 2021-08-19 Americo Fernandes Multi-function oral appliance
US11851510B2 (en) 2020-03-02 2023-12-26 Align Technology, Inc. Low viscosity photo-curable resins for the direct fabrication of orthodontic appliances
US11845868B2 (en) 2020-03-13 2023-12-19 Align Technology, Inc. Weak covalent crosslinks in thermoset materials for increased toughness
US20220031426A1 (en) * 2020-07-31 2022-02-03 Align Technology, Inc. Direct fabrication of mixed metal and polymer orthodontic devices
US11661468B2 (en) 2020-08-27 2023-05-30 Align Technology, Inc. Additive manufacturing using variable temperature-controlled resins
CN113499534A (en) * 2021-08-11 2021-10-15 牡丹江医学院 Fixed-point nursing device for dental ulcer
CN114391985A (en) * 2021-12-27 2022-04-26 四川大学 Bracket-free invisible orthodontic base station utilizing dental implant anchorage

Also Published As

Publication number Publication date
US20080293007A1 (en) 2008-11-27
US8075309B2 (en) 2011-12-13
EP1824410A4 (en) 2015-03-11
JP2012086076A (en) 2012-05-10
JP5004295B2 (en) 2012-08-22
EP1824410B1 (en) 2018-10-17
US20120082950A1 (en) 2012-04-05
WO2006060547A3 (en) 2007-12-21
JP2008521514A (en) 2008-06-26
EP1824410A2 (en) 2007-08-29
WO2006060547A2 (en) 2006-06-08
US8439674B2 (en) 2013-05-14

Similar Documents

Publication Publication Date Title
US8439674B2 (en) Systems and methods for intra-oral drug delivery
US7947508B2 (en) Systems and methods for intra-oral diagnosis
US7766658B2 (en) Systems and methods for intra-oral diagnosis
US20060115782A1 (en) Systems and methods for coating a dental appliance
EP1318761B1 (en) System for concurrent tooth repositioning and substance delivery
ES2357939T3 (en) ORAL ADMINISTRATION SYSTEM OF SUBSTANCES SIMULTANEOUSLY TO REALINATION OF TEETH.
CA2071970C (en) Method and system for treating periodontal disease
JP2008521514A5 (en)
US6106286A (en) Method and device for administering medicine to the periodontium
US20230233419A1 (en) Pharmaceutical formulation
Nozawa et al. Connective Tissue--Bone Onlay Graft with Enamel Matrix Derivative for Treatment of Gingival Recession: A Case Report.
Aspalli et al. Efficacy and Safety of a Novel Water Flosser—A Comparative Clinical Study
Bathinda et al. Accelerated Orthodontics: A Frontier in Orthodontic Treatment

Legal Events

Date Code Title Description
AS Assignment

Owner name: ALIGN TECHNOLOGY, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LI, CHUNHUA;CARLYLE, WENDA C.;DE SMEDT, PHILIPPE;AND OTHERS;REEL/FRAME:017288/0040;SIGNING DATES FROM 20041116 TO 20041122

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION